KR101241744B1 - New chloride-containing allylating reagents and stereoselective ppeparation method of derivatives of vinyl chlorohydrins and vinyl oxiranes using the same - Google Patents

New chloride-containing allylating reagents and stereoselective ppeparation method of derivatives of vinyl chlorohydrins and vinyl oxiranes using the same Download PDF

Info

Publication number
KR101241744B1
KR101241744B1 KR1020100082150A KR20100082150A KR101241744B1 KR 101241744 B1 KR101241744 B1 KR 101241744B1 KR 1020100082150 A KR1020100082150 A KR 1020100082150A KR 20100082150 A KR20100082150 A KR 20100082150A KR 101241744 B1 KR101241744 B1 KR 101241744B1
Authority
KR
South Korea
Prior art keywords
formula
group
reacting
chlorine
compound
Prior art date
Application number
KR1020100082150A
Other languages
Korean (ko)
Other versions
KR20110098599A (en
Inventor
유찬모
이보빈
Original Assignee
성균관대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성균관대학교산학협력단 filed Critical 성균관대학교산학협력단
Publication of KR20110098599A publication Critical patent/KR20110098599A/en
Application granted granted Critical
Publication of KR101241744B1 publication Critical patent/KR101241744B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)

Abstract

본 발명은 염소 함유 알릴전이시약을 이용한 비닐 클로로하이드린 및 비닐 옥시란의 입체선택적 제조방법에 관한 것이다. 이를 통해 다양한 치환체의 비닐 클로로하이드린 및 비닐옥시란을 합성할 수 있으며 가능한 모든 입체이성질체를 선택적으로 얻을 수 있다. 또한, 본 발명은 생리활성이 있는 광학활성 천연물 및 의약품의 합성 중간체로 이용될 수 있는 폰티카에폭사이드의 신규 합성 방법을 제공한다.The present invention relates to a stereoselective method for preparing vinyl chlorohydrin and vinyl oxirane using chlorine-containing allyltransfer reagents. This makes it possible to synthesize vinyl chlorohydrin and vinyloxirane of various substituents and to selectively obtain all possible stereoisomers. In addition, the present invention provides a novel method for synthesizing ponta epoxide which can be used as a synthetic intermediate of optically active natural products and pharmaceuticals with physiological activity.

Description

신규 염소-함유 알릴전이시약 및 이를 이용한 비닐클로로하이드린 및 비닐옥시란의 입체선택적 제조 방법{NEW CHLORIDE-CONTAINING ALLYLATING REAGENTS AND STEREOSELECTIVE PPEPARATION METHOD OF DERIVATIVES OF VINYL CHLOROHYDRINS AND VINYL OXIRANES USING THE SAME}New Chlorine-Containing ALLYLATING REAGENTS AND STEREOSELECTIVE PPEPARATION METHOD OF DERIVATIVES OF VINYL CHLOROHYDRINS AND VINYL OXIRANES USING THE SAME}

본 발명은 신규 염소-함유 알릴전이시약 및 이를 이용한 비닐클로로하이드린 및 비닐옥시란의 입체선택적 제조방법에 관한 것이다.The present invention relates to novel chlorine-containing allyltransfer reagents and to stereoselective preparation of vinylchlorohydrin and vinyloxirane using the same.

또한, 본 발명은 비닐옥시란 유도체의 일종인 폰티카에폭사이드의 제조방법에 관한 것이다.The present invention also relates to a method for producing pontica epoxide, which is a kind of vinyl oxirane derivative.

호모알릴알코올은 비교적 단순하지만 하이드록시기와 올레핀기가 포함되어 있기 때문에 기능기 전환에 의한 유용한 화합물로의 합성이 가능하기에 다양한 분야에서 응용 및 연구되고 있다. 이러한 호모알릴알코올은 알데히드의 알릴부가반응을 통해 얻어진다. 특히, 이러한 알데히드의 알릴부가반응은 비대칭합성분야에서 알돌반응과 함께 화학 분야에서 가장 많이 연구되고 있는 분야이다. 이러한 반응을 통해 생성되는 호모알릴알코올은 비교적 단순한 형태의 부분입체 선택반응으로부터 촉매비대칭반응에 이르기까지 연구대상으로 많이 활용되고 있다. Homoallyl alcohol is relatively simple, but because it contains a hydroxyl group and an olefin group, since it is possible to synthesize a useful compound by functional group conversion has been applied and researched in various fields. Such homoallyl alcohol is obtained through the allyl addition reaction of aldehyde. In particular, the allyl addition reaction of the aldehyde is the most studied field in the chemical field together with the aldol reaction in the asymmetric synthesis field. Homoallyl alcohol produced through such a reaction has been widely used as a research object ranging from a relatively simple type of stereostereoselection reaction to a catalyst asymmetry reaction.

1980년대 초반에, 독일의 호프만은 캠퍼유도체를 이용하여 카이랄 조절기가 포함된 당량의 알릴보란을 합성하고 이를 알데히드와의 반응하여 광학활성 생성물을 얻은 새로운 유형의 비대칭 합성방법을 제시한바 있다. 이러한 비대칭 합성방법을 통해 얻은 화합물은 입체선택성 및 수득율의 측면에서 괄목할 만한 진보를 이룩하였고 최근까지도 매우 복잡한 입체구조의 생리활성 천연물의 구축을 위한 효율적인 방법론임이 증명되고 있다. In the early 1980s, Hoffmann, Germany, proposed a new type of asymmetric synthesis method using a camphor derivative to synthesize an equivalent allylborane containing a chiral regulator and react with it to obtain an optically active product. Compounds obtained through this asymmetric synthesis method have made remarkable advances in terms of stereoselectivity and yield, and until recently, it has been proved to be an efficient methodology for constructing physiologically active natural products of very complex stereostructures.

그 이후 많은 화학자들이 이 연구 분야에 참여하여 독특한 형태의 개선된 방법론을 개발하였다. 이러한 연구에도 불구하고 현재까지는 매우 단순한 알릴전이시약만이 개발되었으며, 기능기가 포함된 알릴전이시약의 개발이 기대되고 있는 상황이다.Since then, many chemists have participated in this field of research to develop unique forms of improved methodologies. Despite these studies, only very simple allyl transfer reagents have been developed so far, and development of allyl transfer reagents containing functional groups is expected.

이러한 일례로, 문헌 [Org . Chem .(Hu, S.; Jayaraman, S.; Oehlschlager, A. C. J. Org . Chem . 1996, 61, 7513-7520)]에서는 클로로알릴전이반응에 관하여 설명하고 있으나, 이는 단지 하나의 부분입체이성질체를 합성할 수 있다는 점, 반응조건이 매우 강한 염기 조건 하에서만 이루어져 다른 기능기를 도입할 수 없다는 점, 반응수율과 입체선택성이 이상적이지 않다는 점에서 효율성이 떨어진다는 문제점이 있었다.In this example, Org . Chem . ( Hu, S .; Jayaraman, S .; Oehlschlager, AC J. Org . Chem . 1996, 61 , 7513-7520) describe chloroallyl transfer reactions, but only one diastereomer is described. There is a problem in that the efficiency is poor in that it can be synthesized, the reaction conditions are made only under very strong base conditions, and other functional groups cannot be introduced, and the reaction yield and stereoselectivity are not ideal.

이에 본 발명자들은 다양한 화합물로 전환할 수 있는 알릴전이반응을 구상하던 중, 새로운 염소 함유 알릴전이시약을 알게 되어 본 발명을 완성하기에 이르렀다. The present inventors came up with a new chlorine-containing allyl transfer reagent while envisioning an allyl transfer reaction that can be converted into various compounds, thereby completing the present invention.

본 발명의 목적은 부분입체이성질체 및 거울상 이성질체 모두를 선택적으로 제조 가능하게 하는 동시에 반응 수율과 입체선택성 등의 효율성을 개선시키고 온화한 조건에서 반응이 가능한 신규 염소 함유 알릴전이시약을 제공하는 것이다.It is an object of the present invention to provide novel chlorine-containing allyltransferases capable of selectively preparing both diastereomers and enantiomers, while improving the efficiency of reaction yields, stereoselectivity and the like and reacting under mild conditions.

본 발명의 다른 목적은 본 발명의 염소 함유 알릴전이시약을 이용하는 광학활성 비닐클로로하이드린 및 비닐옥시란의 제조방법을 제공하는 것이다.Another object of the present invention is to provide a method for preparing optically active vinylchlorohydrin and vinyloxirane using the chlorine-containing allyltransferase of the present invention.

본 발명의 또 다른 목적은 비닐옥시란 유도체의 일종으로서 생리활성을 가지고 있는 광학활성 천연물인 폰티카에폭사이드(Ponticaepoxide)의 신규 합성 방법을 제공하는 것이다. It is still another object of the present invention to provide a novel method for synthesizing ponticae epoxide (Ponticaepoxide), an optically active natural product having a physiological activity as a kind of vinyl oxirane derivative.

상기 목적을 달성하기 위하여, 본 발명은 설퍼일리드와 카이랄 보란을 반응시켜 얻은 염소 함유 알릴전이시약을 제공하고, 이는 비대칭합성에 매우 유용하다.In order to achieve the above object, the present invention provides a chlorine-containing allyl transfer reagent obtained by reacting sulfyllide with chiral borane, which is very useful for asymmetric synthesis.

구체적으로, 본 발명은Specifically, the present invention provides

(i) 화학식 8-1 또는 화학식 9-1 중에서 선택되는 염소 함유 설퍼 일리드(sulfur ylide), 및(i) chlorine-containing sulfur ylides selected from formulas 8-1 or 9-1, and

[화학식 8-1][Formula 8-1]

Figure 112010054670377-pat00001
Figure 112010054670377-pat00001

[화학식 9-1][Formula 9-1]

Figure 112010054670377-pat00002
Figure 112010054670377-pat00002

(ii) 화학식 13 또는 화학식 13-1 중에서 선택되는 카이랄 보란 (ii) a chiral borane selected from formula 13 or formula 13-1

[화학식 13] [Chemical Formula 13]

Figure 112010054670377-pat00003
Figure 112010054670377-pat00003

[화학식 13-1][Formula 13-1]

Figure 112010054670377-pat00004
Figure 112010054670377-pat00004

을 반응시켜 얻은 염소 함유 알릴전이시약을 제공한다. 화학식 13 또는 화학식 13-1의 화합물에서 치환기 Tol은 4-메틸페닐이다.It provides a chlorine-containing allyl transfer reagent obtained by reacting. In the compound of Formula 13 or Formula 13-1, the substituent Tol is 4-methylphenyl.

본 발명의 염소 함유 알릴전이시약은 예를 들어, 화학식 8-1의 설퍼 일리드와 화학식 13의 카이랄 보란을 반응시켜 얻을 수 있거나, 또는 화학식 9-1의 설퍼 일리드와 화학식 13의 카이랄 보란을 반응시켜 얻을 수 있다. 본 발명의 염소 함유 알릴전이시약은 분리되지 않는 중간체이고, 하기 표 1에 나타낸 바와 같은 구조식으로 표현할 수 있다.The chlorine-containing allyltransfer reagent of the present invention may be obtained, for example, by reacting a sulfide of Formula 8-1 with a chiral borane of Formula 13, or a sulfide of Formula 9-1 and a chiral of Formula 13 It can be obtained by reacting borane. The chlorine-containing allyltransfer reagent of the present invention is an intermediate which cannot be separated and can be represented by a structural formula as shown in Table 1 below.


Figure 112010054670377-pat00005


Figure 112010054670377-pat00005


Figure 112010054670377-pat00006

Figure 112010054670377-pat00006

Figure 112010054670377-pat00007


Figure 112010054670377-pat00007


Figure 112010054670377-pat00008

Figure 112010054670377-pat00008

본 발명은 본 발명의 염소 함유 알릴전이시약과 화학식 14의 알데히드를 반응시켜, 화학식 15 또는 화학식 15-1의 anti-비닐클로로하이드린을 제조하는 방법 및 화학식 16 또는 화학식 16-1의 syn-비닐클로로하이드린을 제조하는 방법을 더 제공한다. The present invention is a method for preparing an anti-vinylchlorohydrin of Formula 15 or Formula 15-1 by reacting a chlorine-containing allyltransfer reagent of the present invention with an aldehyde of Formula 14 and syn-vinyl of Formula 16 or Formula 16-1 Further provided are methods for preparing chlorohydrin.

[화학식 14][Formula 14]

R-CHOR-CHO

[화학식 15][Formula 15]

Figure 112010054670377-pat00009
Figure 112010054670377-pat00009

[화학식 16][Chemical Formula 16]

Figure 112010054670377-pat00010
Figure 112010054670377-pat00010

[화학식 15-1][Formula 15-1]

Figure 112010054670377-pat00011
Figure 112010054670377-pat00011

[화학식 16-1][Formula 16-1]

Figure 112010054670377-pat00012
Figure 112010054670377-pat00012

본 발명은 본 발명의 염소 함유 알릴전이시약을 사용하여 제조된 화학식 15의 anti-비닐클로로하이드린을 염기와 반응시켜 화학식 17의 트랜스-비닐옥시란을 제조하는 방법을 더 제공한다. The present invention further provides a method of preparing a trans-vinyl oxirane of formula 17 by reacting an anti-vinylchlorohydrin of formula 15 prepared with a chlorine-containing allyltransferase of the present invention with a base.

[화학식 17][Chemical Formula 17]

Figure 112010054670377-pat00013
Figure 112010054670377-pat00013

본 발명은 본 발명의 염소 함유 알릴전이시약을 사용하여 제조된 화학식 15-1의 anti-비닐클로로하이드린을 염기와 반응시켜 화학식 17-1의 트랜스-비닐옥시란을 제조하는 방법을 더 제공한다. The present invention further provides a method for preparing a trans-vinyl oxirane of formula (17-1) by reacting an anti-vinylchlorohydrin of formula (15-1) prepared with a chlorine-containing allyltransferase of the present invention with a base. .

[화학식 17-1][Formula 17-1]

Figure 112010054670377-pat00014
Figure 112010054670377-pat00014

본 발명은 본 발명에 따른 염소 함유 알릴전이시약을 사용하여 제조된 화학식 16의 syn-비닐클로로하이드린을 염기와 반응시켜 화학식 18의 시스-비닐옥시란을 제조하는 방법을 더 제공한다.The present invention further provides a process for preparing cis-vinyloxirane of formula (18) by reacting a syn-vinylchlorohydrin of formula (16) prepared using a chlorine-containing allyltransferase according to the present invention with a base.

[화학식 18] [Chemical Formula 18]

Figure 112010054670377-pat00015
Figure 112010054670377-pat00015

본 발명은 본 발명에 따른 염소 함유 알릴전이시약을 사용하여 제조된 화학식 16-1의 syn-비닐클로로하이드린을 염기와 반응시켜 화학식 18-1의 시스 비닐옥시란을 제조하는 방법을 더 제공한다.The present invention further provides a process for preparing cis vinyloxirane of formula (18-1) by reacting syn-vinylchlorohydrin of formula (16-1) prepared with a chlorine-containing allyltransferase according to the present invention with a base. .

[화학식 18-1][Formula 18-1]

Figure 112010054670377-pat00016
Figure 112010054670377-pat00016

상기 식들에서, Tol은 4-메틸페닐이고, R은 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 아릴기, 아랄킬기, 아랄케닐기, 또는 아랄키닐기이고, 바람직하게는 탄소수 1 내지 12의 알킬기, 탄소수 2 내지 12의 알케닐기, 탄소수 2 내지 12의 알키닐기, 탄소수 3 내지 12의 시클로알킬기, 탄소수 6 내지 12의 아릴기, 탄소수 1 내지 12의 알킬기가 탄소수 6 내지 12의 아릴기로 치환된 아랄킬기, 탄소수 2 내지 12의 알케닐기가 탄소수 6 내지 12의 아릴기로 치환된 아랄케닐기, 또는 탄소수 2 내지 12의 알키닐기가 탄소수 6 내지 12의 아릴기로 치환된 아랄키닐기이고, 가장 바람직하게는 페닐, 벤질, 시클로헥실, 페닐에테닐, 페닐에티닐 또는 페닐에틸이다.In the above formulas, Tol is 4-methylphenyl, R is an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group, an aralkyl group, an arkenyl group, or an aralkylyl group, preferably an alkyl group having 1 to 12 carbon atoms, Aralkyl groups in which an alkenyl group having 2 to 12 carbon atoms, an alkynyl group having 2 to 12 carbon atoms, a cycloalkyl group having 3 to 12 carbon atoms, an aryl group having 6 to 12 carbon atoms, and an alkyl group having 1 to 12 carbon atoms is substituted with an aryl group having 6 to 12 carbon atoms , An alkenyl group in which an alkenyl group having 2 to 12 carbon atoms is substituted with an aryl group having 6 to 12 carbon atoms, or an aralkylyl group in which an alkynyl group having 2 to 12 carbon atoms is substituted with an aryl group having 6 to 12 carbon atoms, most preferably phenyl , Benzyl, cyclohexyl, phenylethenyl, phenylethynyl or phenylethyl.

본 발명은 본 발명의 설퍼 일리드의 전구체인 화학식 8 또는 화학식 9의 설포늄 이온을 더 제공한다.The present invention further provides sulfonium ions of the formula (8) or formula (9) which are precursors of the sulfides of the present invention.

[화학식 8][Formula 8]

Figure 112010054670377-pat00017
Figure 112010054670377-pat00017

(식중, Ts는

Figure 112010054670377-pat00018
이고, Me는 메틸임)(Ts is
Figure 112010054670377-pat00018
Me is methyl)

[화학식 9][Chemical Formula 9]

Figure 112010054670377-pat00019
Figure 112010054670377-pat00019

(식중, Ts는

Figure 112010054670377-pat00020
이고, Me는 메틸임)(Ts is
Figure 112010054670377-pat00020
Me is methyl)

본 발명은 본 발명에 따른 염소 함유 알릴전이시약을 이용하는 폰티카에폭사이드의 제조방법을 더 제공한다. The present invention further provides a method for preparing ponticaepoxide using a chlorine-containing allyl transition reagent according to the present invention.

본 발명은 신규 염소-함유 알릴전이시약을 이용하여 비닐클로로하이드린 및 비닐옥시란을 제조함으로써, 모든 입체이성질체(부분입체이성질체 및 거울상이성질체)의 높은 선택적 합성을 제공하는 효과가 있다. 본 발명에 따른 염소-함유 알릴전이시약을 이용하는 방법은 온화한 조건에서 합성할 수 있어 보다 안정하게 제조할 수 있는 장점이 있다. The present invention has the effect of providing high selective synthesis of all stereoisomers (diastereomers and enantiomers) by preparing vinylchlorohydrin and vinyloxirane using novel chlorine-containing allyltransfer reagents. Method using the chlorine-containing allyl transition reagent according to the present invention has the advantage that can be synthesized in a mild condition more stable production.

또한, 본 발명은 폰티카에폭사이드의 합성 방법을 최초로 제공하는 효과가 있다.In addition, the present invention has the effect of providing a method for synthesizing ponta epoxide for the first time.

이하에, 본 발명을 더욱 상세하게 설명한다.
EMBODIMENT OF THE INVENTION Below, this invention is demonstrated in detail.

A. A. 설퍼Sulfur 일리드의Ilid 전구체인 화학식 8 또는 9의  Precursor of Formula 8 or 9 설포늄Sulfonium 이온의 제조 Preparation of ions

본 발명에 따른 설퍼 일리드의 전구체인 화학식 8 또는 9의 설포늄 이온은 하기 반응식 1에 따라 제조할 수 있다.Sulfonium ions of the formula (8) or (9), which are the precursors of the sulfides according to the present invention, may be prepared according to Scheme 1 below.

[반응식 1][Reaction Scheme 1]

Figure 112010054670377-pat00021
Figure 112010054670377-pat00021

화학식 1의 화합물((E)-클로로알릴알코올) 및 화학식 2의 화합물((Z)-클로로알릴알코올)의 합성은 문헌에 보고된 방법 그대로 또는 그 방법을 개선하여 수행할 수 있다.Synthesis of the compound of formula (1) (( E ) -chloroallyl alcohol) and the compound of formula (2) ((Z) -chloroallyl alcohol) can be carried out as it is reported in the literature or by improving the method.

화학식 1의 화합물은 예를 들어, 에피클로로하이드린을 테트라메틸에틸렌디아민(TMEDA) 존재 하에서 부틸리튬과의 반응으로부터 합성하여 얻을 수 있다. 이러한 반응은 (E)-이성질체와 (Z)-이성질체를 약 85:15의 혼합물로 생성시킨다. 생성된 혼합체와 포타슘 tert-부톡사이드(t-BuOK)를 실온에서 천천히 80℃까지 가열하여 10시간 이상 반응을 진행한 후 물을 첨가하여 반응을 종결시킨 후 디에틸에테르(Et2O)로 추출할 수 있다. 상기 추출 방법으로서 증류를 이용함으로써 순수한 화학식 1의 화합물 (E)-3-클로로-2-프로펜-1-올을 얻을 수 있다.The compound of formula 1 can be obtained, for example, by synthesizing epichlorohydrin from the reaction with butyllithium in the presence of tetramethylethylenediamine (TMEDA). This reaction produces the (E) -isomer and (Z) -isomer in a mixture of about 85:15. The resulting mixture and potassium tert-butoxide ( t- BuOK) were slowly heated to room temperature at 80 ° C. for at least 10 hours, followed by addition of water to terminate the reaction, followed by extraction with diethyl ether (Et 2 O). can do. By using distillation as the extraction method, pure compound ( E ) -3-chloro-2-propen-1-ol of formula (1) can be obtained.

화학식 2의 화합물은 예를 들어, 문헌 (Urdaneta , N. A.; Salazar , J.; Herrera, J. C.; Lopez , S. E. Synthetic Communications , 2004, 34, 657]에 기재된 방법을 이용하여 에틸프로피올레이트로부터 합성할 수 있다.Compounds of formula (2) are described, for example, in Urdaneta , NA; Salazar , J .; Herrera, JC; Lopez , SE Synthetic Communications , 2004, 34, 657 ] can be synthesized from ethyl propiolate using the method described.

이렇게 합성된 화학식 1의 화합물 또는 화학식 2의 화합물을 용기에 넣은 뒤 용매를 첨가한다. 그 후 반응 온도에서 용기에 화학식 3의 화합물(부틸리튬)을 첨가한 후 한 번에 화학식 4의 화합물인 파라-톨루엔설포닐 클로라이드(p-TsCl)를 첨가한다. 반응온도는 일반적으로 -78℃~0℃, 바람직하게는 -78℃~-20℃가 적당하며, 저온일 때 반응이 효과적이다.The compound of Formula 1 or the compound of Formula 2 thus synthesized is placed in a container, and then a solvent is added. Thereafter, the compound of formula 3 (butyllithium) is added to the vessel at the reaction temperature, and then para-toluenesulfonyl chloride ( p- TsCl) is added at one time. The reaction temperature is generally -78 ° C to 0 ° C, preferably -78 ° C to -20 ° C, and the reaction is effective at low temperatures.

상기 온도에서 3시간 동안 반응시킨 후, 실리카젤 크로마토그래피로 정제하여 화학식 5의 화합물[(E)-3-클로로알릴-4-메틸벤젠설포네이트]을 합성할 수 있다. 이렇게 얻은 화학식 5의 화합물은 용매 중에서 화학식 7의 테트라하이드로사이오펜과 반응시켜 하얀색 염을 형성하고, 용매를 제거하여 화학식 8의 화합물[(E)-1-(3-클로로알릴)-테트라하이드로-1-H-사이오페늄-4-메틸벤젠설포네이트]을 얻을 수 있다. 용매는 테트라하이드로퓨란이 바람직하다.After reacting for 3 hours at the above temperature, it is purified by silica gel chromatography to synthesize a compound of Formula 5 [( E ) -3-chloroallyl-4-methylbenzenesulfonate]. The compound of Formula 5 thus obtained is reacted with tetrahydrothiophene of Formula 7 in a solvent to form a white salt, and the solvent is removed to remove the compound of Formula 8 [( E ) -1- (3-chloroallyl) -tetrahydro- 1-H-thiophenium-4-methylbenzenesulfonate] can be obtained. The solvent is preferably tetrahydrofuran.

또한, 이와 동일한 방법으로 화학식 2의 화합물을 출발 물질로 사용하여 화학식 6의 화합물[(Z)-3-클로로알릴-4-메틸벤젠설포네이트]을 얻고, 화학식 6의 화합물로부터 화학식 9의 화합물을 얻을 수 있다.
In the same manner, the compound of formula 2 was used as a starting material to obtain a compound of formula 6 [(Z) -3-chloroallyl-4-methylbenzenesulfonate], and the compound of formula 9 was obtained from the compound of formula 6. You can get it.

B. 염소 함유 B. Chlorine 알릴전이시약Allyl Transfer Reagent 및 이를 사용하는  And using it 비닐클로로하이드린의Vinylchlorohydrin 입체선택적 제조 Stereoselective manufacturing

본 발명은 설퍼 일리드와 카이랄보란을 반응시켜 새로운 염소 함유 알릴전이시약을 제조하고, 이를 알데히드와 반응시켜 광학활성 비닐클로로하이드린을 제조한다. 구체적인 반응식은 하기 반응식 2를 통해 확인할 수 있다.The present invention is to react the sulfur yilide and chiral borane to prepare a new chlorine-containing allyl transfer reagent, and reacted with the aldehyde to produce an optically active vinyl chlorohydrin. Specific reaction schemes can be identified through the following scheme 2.

[반응식 2][Reaction Scheme 2]

Figure 112010054670377-pat00022
Figure 112010054670377-pat00022

화학식 15-1의 화합물 또는 화학식 16-1의 화합물은 화학식 11-1의 화합물 및 화학식 13-1의 카이랄보란을 사용한 것을 제외하고는 반응식 2와 동일한 방법으로 제조할 수 있다. A compound of Formula 15-1 or a compound of Formula 16-1 may be prepared by the same method as in Scheme 2, except that the compound of Formula 11-1 and the chiralborane of Formula 13-1 are used.

[화학식 11-1][Formula 11-1]

Figure 112010054670377-pat00023

Figure 112010054670377-pat00023

B-1. 염소 함유 B-1. Chlorine 알릴전이시약의Allyl transfer reagent 제조 Produce

화학식 8 또는 9의 설포늄 이온을 용매 중에서 메틸리튬과 반응시켜 얻을 수 있다. 반응 온도는 -40℃가 바람직하다. 상기 온도에서 광학 순도가 높다. The sulfonium ions of formula 8 or 9 can be obtained by reacting with methyllithium in a solvent. As for reaction temperature, -40 degreeC is preferable. The optical purity is high at this temperature.

이렇게 생성된 설퍼 일리드를 화학식 13의 카이랄 보란과 반응시켜 염소 함유 알릴전이시약을 제조한다. The resulting sulfur illide is reacted with a chiral borane of Formula 13 to prepare a chlorine-containing allyltransfer reagent.

화학식 13의 카이랄 보란[(4R,5R)-4,5-디페닐-1,3-디토실-1,3,2-디아자보롤리딘]은 화학식 11의 화합물[(1R,2R)-1,2-디페닐-N1,N2-디토실에탄-1,2-디아민]과 3 당량의 화학식 12의 화합물(보란, BH3SMe2)의 화합물을 용매 중에서 고온 및 장시간 반응하여 얻을 수 있다. 여기서, 용매는 톨루엔이 바람직하고, 반응온도는 80℃가 바람직하고, 반응시간은 20~24시간이 적당하고, 24시간이 바람직하다. 이후, 감압 증류하여 휘발성 물질을 제거하고 무수 용매에 녹여 바로 사용할 수 있다. 화학식 11의 화합물의 구조적인 특성이 입체성 전이에 매우 효율적이었음을 확인할 수 있다. 여기서, 용매는 테트라하이드로퓨란이 바람직하다.A chiral borane [(4R, 5R) -4,5-diphenyl-1,3-ditosyl-1,3,2-diazaboolidine] of formula 13 is a compound of formula 11 [(1R, 2R)- 1,2-diphenyl-N1, N2-ditosylethane-1,2-diamine] and 3 equivalents of the compound of formula 12 (borane, BH 3 SMe 2 ) can be obtained by high temperature and long reaction in a solvent. . Here, toluene is preferable, as for a solvent, 80 degreeC of reaction temperature is preferable, 20-24 hours are suitable for reaction time, and 24 hours are preferable. Thereafter, distillation under reduced pressure removes the volatiles and can be used immediately by dissolving in anhydrous solvent. It can be seen that the structural properties of the compound of formula 11 were very efficient for steric transition. The solvent is preferably tetrahydrofuran.

본 발명에 따라 제조된 설퍼 일리드는 매우 불안정하여 빠른 시간 내에 화학식 13의 카이랄 보란과 반응을 시켜야 하고, 특히 10분 이내에 반응시키는 것이 바람직하다.
The sulfides prepared according to the invention are very unstable and must react with the chiral borane of the formula (13) in a short time, particularly preferably within 10 minutes.

B-2. B-2. 비닐클로로하이드린의Vinylchlorohydrin 입체선택적 제조 Stereoselective manufacturing

본 발명의 염소 함유 알릴전이시약을 화학식 14의 알데히드와 반응시켜 화학식 15의 화합물(anti-비닐클로로하이드린)을 제조할 수 있다.The chlorine-containing allyltransfer reagent of the present invention may be reacted with an aldehyde of Formula 14 to prepare a compound of Formula 15 (anti-vinylchlorohydrin).

[화학식 14][Formula 14]

RCHORCHO

상기 식에서, R은 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 아릴기, 아랄킬기, 아랄케닐기, 또는 아랄키닐기이고, 바람직하게는 탄소수 1 내지 12의 알킬기, 탄소수 2 내지 12의 알케닐기, 탄소수 2 내지 12의 알키닐기, 탄소수 3 내지 12의 시클로알킬기, 탄소수 6 내지 12의 아릴기, 탄소수 1 내지 12의 알킬기가 탄소수 6 내지 12의 아릴기로 치환된 아랄킬기, 탄소수 2 내지 12의 알케닐기가 탄소수 6 내지 12의 아릴기로 치환된 아랄케닐기, 또는 탄소수 2 내지 12의 알키닐기가 탄소수 6 내지 12의 아릴기로 치환된 아랄키닐기이고, 가장 바람직하게는 페닐, 벤질, 시클로헥실, 페닐에테닐, 페닐에티닐 또는 페닐에틸이다.In the above formula, R is an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group, an aralkyl group, an arkenyl group, or an aralkyl group, preferably an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 2 to 12 carbon atoms, Aralkyl groups in which an alkynyl group having 2 to 12 carbon atoms, a cycloalkyl group having 3 to 12 carbon atoms, an aryl group having 6 to 12 carbon atoms, an alkyl group having 1 to 12 carbon atoms is substituted with an aryl group having 6 to 12 carbon atoms, and an alkenyl having 2 to 12 carbon atoms The group is an arkenyl group substituted with an aryl group having 6 to 12 carbon atoms, or an alkynyl group having 2 to 12 carbon atoms substituted with an aryl group having 6 to 12 carbon atoms, and most preferably phenyl, benzyl, cyclohexyl, or phenyl. Tenyl, phenylethynyl or phenylethyl.

본 발명에 따른 비닐클로로하이드린의 제조 방법의 반응 온도는 -78℃가 바람직하다. As for the reaction temperature of the manufacturing method of vinylchlorohydrin which concerns on this invention, -78 degreeC is preferable.

화학식 9의 화합물을 출발물질로 하여 동일한 방법을 수행하면, 화학식 16의 화합물(syn-비닐클로로하이드린)을 우수한 선택성으로 얻을 수 있다.When the same method is performed using the compound of Formula 9 as a starting material, the compound of Formula 16 (syn-vinylchlorohydrin) may be obtained with excellent selectivity.

본 발명의 제조 방법은 안정한 설포늄 이온으로부터 시작하여 단일 용기 내에서 연속 조작을 통해 비닐클로로하이드린을 합성할 수 있다. 이러한 반응은 공기 중에 불안정한 화합물(설퍼 일리드)을 반응 용기 내에서 바로 처리하여 합성하는바 반응의 효율성을 높을 수 있다는 장점이 있다.The process of the present invention can synthesize vinylchlorohydrin starting from stable sulfonium ions through continuous operation in a single vessel. This reaction has the advantage of increasing the efficiency of the reaction by synthesizing the unstable compound (sulfur lead) in the air directly in the reaction vessel.

본 발명에 따른 제조 방법의 부분 입체선택성은 99%이상으로 모든 반응에서 매우 순도 높은 부분입체이성질체를 생성한다. 또한, 절대 입체선택성 또한 매우 높아 생성물의 MTPA-에스테르의 NMR 분석과 카이랄 고성능액체크로마토그래피(HPLC, Chiralcel AD-H)로 분석한 결과 93 ~ >99% ee(Enantiomeric excess)를 나타내는 것을 특징으로 한다.
The partial stereoselectivity of the preparation process according to the invention produces more than 99% of the highly pure diastereomers in all reactions. In addition, the absolute stereoselectivity is also very high, NMR analysis of the product MTPA-ester and chiral high performance liquid chromatography (HPLC, Chiralcel AD-H) as a result of the 93 ~> 99% ee (Enantiomeric excess) characterized in that characterized do.

C. C. 비닐옥시란의Vinyloxirane 입체선택적 제조 Stereoselective manufacturing

앞서 살펴본 A 및 B에 기재한 방법을 통해 얻은 광학활성 비닐클로로하이드린은 염기 조건하에서 광학활성 비닐옥시란으로 입체선택적으로 합성될 수 있다. 이렇게 생성된 비닐옥시란은 생리활성 천연물의 주요부분일 뿐만 아니라 유용한 화학 변환의 기질분자로도 사용될 수 있다. 하기 반응식 3을 통해 비닐옥시란의 제조 과정을 상세히 설명한다. The optically active vinylchlorohydrin obtained through the method described in A and B described above can be stereoselectively synthesized into optically active vinyloxirane under basic conditions. The vinyloxirane thus produced can be used not only as a major part of bioactive natural products but also as a substrate molecule of useful chemical transformation. The process of preparing vinyloxirane is described in detail through Scheme 3 below.

[반응식 3] Scheme 3

Figure 112010054670377-pat00024
Figure 112010054670377-pat00024

부분입체이성질체인 화학식 15의 화합물 또는 16의 화합물은 염기 조건에서 비닐 옥시란으로 합성될 수 있다. 염기로는 화학식 19의 DBU(1,8-디아자바이시클로[5,4,0]운데스-7-엔)을 사용하는 것이 바람직하다.Compounds of formula 15 or 16 which are diastereomers can be synthesized with vinyl oxirane at basic conditions. It is preferable to use DBU (1,8-diazabicyclo [5,4,0] undes-7-ene) of formula (19) as the base.

화학식 15의 화합물은 화학식 17의 트랜스 비닐옥시란으로, 화학식 16의 화합물은 화학식 18의 시스 비닐옥시란으로 제조될 수 있다. 화학식 15 내지 18에서, R은 화학식 14의 알데히드에서 정의한 바와 같다. The compound of formula 15 may be prepared as trans vinyloxirane of formula 17, and the compound of formula 16 may be prepared as cis vinyloxirane of formula 18. In Formulas 15 to 18, R is as defined in the aldehyde of Formula 14.

본 발명에 따른 트랜스/시스 비닐옥시란의 제조 방법에서, 용매는 본 기술 분야에서 통상의 지식을 가진 자가 적절하게 선택할 수 있고, 예를 들면, 디클로로메탄, 테트라하이드로퓨란, 디에틸에테르 등이 있다. 또한, 반응 온도 및 반응 시간은 특별히 한정되지는 않으나, 실온에서 1~3시간 정도 수행하는 것이 적당하다. In the method for producing trans / cis vinyloxirane according to the present invention, the solvent may be appropriately selected by those skilled in the art, for example, dichloromethane, tetrahydrofuran, diethyl ether and the like. . In addition, although reaction temperature and reaction time are not specifically limited, It is suitable to carry out about 1-3 hours at room temperature.

한편, 화학식 17-1의 화합물 또는 화학식 18-1의 화합물은 각각 화학식 15-1의 화합물 또는 화학식 16-1의 화합물로부터 출발하여 동일한 방법으로 제조될 수 있다.
Meanwhile, the compound of Formula 17-1 or the compound of Formula 18-1 may be prepared by the same method starting from the compound of Formula 15-1 or the compound of Formula 16-1, respectively.

D. D. 폰티카에폭사이드의Pontika Epoxide 제조 방법 Manufacturing method

상기 반응식 1 내지 3을 통해, 설퍼일리드 및 카이랄 보란을 반응시켜 얻은 알릴전이시약을 이용하는 다양한 광학활성 비닐클로로하이드린 및 비닐옥시란의 제조방법을 설명하였다.Through Schemes 1 to 3, various optically active vinylchlorohydrins and vinyloxiranes were prepared using allyl transition reagents obtained by reacting sulfyllide and chiral borane.

본 발명에 따른 제조방법을 통해, 폴리아세틸렌 계열의 생리활성 천연물인 폰티카에폭사이드를 합성할 수 있다. 현재까지 폰티카에폭사이드 합성방법은 아직 보고되지 않았다(천연물 추출 및 구조분석, Mann, D.; Hartmann, R. J. Nat . Prod . 1992, 55, 29). 이 계열의 화합물이 다양한 생리활성을 보여주고 있으나 천연에서 얻을 수 있는 양은 매우 한정적이라는 문제로 인하여 이에 대한 합성경로를 발견하는 것은 매우 중요하다.Through the production method according to the present invention, it is possible to synthesize a polyacetylene-based physiologically active natural pontica epoxide. To date, no method of synthesizing ponticaepoxide has been reported (natural extraction and structural analysis, Mann, D .; Hartmann, R. J. Nat . Prod . 1992, 55, 29). Although this class of compounds shows various physiological activities, it is very important to find a synthetic route to them because of the limited amount available in nature.

본 발명은 본 발명에 따른 염소 함유 알릴전이시약을 이용하는 비닐옥시란의 제조방법을 이용하여 폰티카에폭사이드의 제조 방법을 최초로 제공한다. The present invention provides for the first time a method for producing ponticaepoxide using a method for producing vinyloxirane using a chlorine-containing allyltransferase according to the present invention.

구체적으로, 본 발명에 따른 폰티카에폭사이드 제조 방법은,Specifically, the method for producing pontica epoxide according to the present invention,

(S1) 화학식 8의 설포늄 이온을 메틸리튬과 반응시켜 화학식 8-1의 염소 함유 설퍼일리드를 얻는 단계;(S1) reacting sulfonium ions of formula 8 with methyllithium to obtain chlorine-containing sulfides of formula 8-1;

[화학식 8][Formula 8]

Figure 112010054670377-pat00025
Figure 112010054670377-pat00025

(식중, Ts는

Figure 112010054670377-pat00026
이고, Me는 메틸임)(Ts is
Figure 112010054670377-pat00026
Me is methyl)

[화학식 8-1][Formula 8-1]

Figure 112010054670377-pat00027
Figure 112010054670377-pat00027

(S2) 상기 화학식 8-1의 염소 함유 설퍼 일리드와 화학식 13-1의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;(S2) reacting the chlorine-containing sulfide of Formula 8-1 with the chiral borane of Formula 13-1 to obtain an allyl transfer reagent;

[화학식 13-1][Formula 13-1]

Figure 112010054670377-pat00028
Figure 112010054670377-pat00028

(식중, Tol은 4-메틸페닐임)Wherein Tol is 4-methylphenyl

(S3) 상기 알릴전이시약을 화학식 27의 알데히드와 반응시켜 화학식 28의 비닐클로로하이드린을 생성하는 단계; 및(S3) reacting the allyl transfer reagent with an aldehyde of Formula 27 to generate vinylchlorohydrin of Formula 28; And

[화학식 27](27)

Figure 112010054670377-pat00029
Figure 112010054670377-pat00029

[화학식 28](28)

Figure 112010054670377-pat00030
Figure 112010054670377-pat00030

(S4) 상기 비닐클로로하이드린을 DBU와 반응시키는 단계를 포함한다. (S4) reacting the vinylchlorohydrin with DBU.

화학식 27의 알데히드 화합물은 본 기술 분야에서 공지된 방법에 따라 제조할 수 있고, (S1) 단계 내지 (S3) 단계에서 사용되는 용매는 테트라하이드로퓨란이 바람직하고, (S1) 단계의 반응 온도는 -40℃, (S2) 단계 및 (S3) 단계의 반응 온도는 -78℃이고, (S4) 단계에서 사용되는 용매는 본 기술 분야에서 통상의 지식을 가진 자가 적절하게 선택할 수 있으며, 디클로로메탄, 테트라하이드로퓨란, 디에틸에테르 등을 예로 들 수 있고, 반응 시간 및 온도는 특별히 한정되지는 않는다.
The aldehyde compound of formula 27 may be prepared according to a method known in the art, the solvent used in steps (S1) to (S3) is preferably tetrahydrofuran, and the reaction temperature of step (S1) is- The reaction temperature of 40 ° C., (S2) and (S3) is −78 ° C., and the solvent used in (S4) may be appropriately selected by one of ordinary skill in the art, and dichloromethane, tetra Hydrofuran, diethyl ether, etc. are mentioned, The reaction time and temperature are not specifically limited.

이하에서는, 본 발명의 구성을 실시예를 들어 더욱 상세히 설명하지만, 본 발명의 권리범위가 하기 실시예로만 한정되는 것은 아니다.
Hereinafter, the structure of the present invention will be described in more detail with reference to examples, but the scope of the present invention is not limited to the following examples.

실시예Example 1:  One: 설포늄Sulfonium 이온의 합성  Synthesis of Ions

실시예Example 1-1: ( 1-1: ( EE )-3-) -3- 클로로알릴Chloroallyl -4--4- 메틸벤젠설포네이트Methylbenzenesulfonate 합성 synthesis

[화학식 5] [Chemical Formula 5]

Figure 112010054670377-pat00031
Figure 112010054670377-pat00031

(E)-3-클로로알릴-2-프로펜-1-올 1 당량을 오븐에서 건조하고 난 후, 순수한 질소 가스 분위기의 반응용기에 넣은 뒤 무수 테트라히드로퓨란(THF)을 가하였다. -78℃에서 건조된 순수한 질소 분위기의 반응용기에 부틸 리튬 1 당량을 첨가한 후, 한번에 파라톨루엔설폰닐 클로라이드 1.1 당량을 첨가하였다. 같은 온도에서 3시간 동안 이 반응을 계속하여 진행하였다. 염화나트륨을 넣어서 반응을 종결한 후 디에틸에테르로 추출한 다음, 황산마그네슘(MgSO4)으로 건조시켰다. 용매를 감압증류한 후, 실리카젤 크로마토그래피(SiO2)로 정제하여 화학식 5의 화합물을 합성하였다. After drying 1 equivalent of ( E ) -3-chloroallyl-2-propene-1-ol in an oven, it was placed in a reaction vessel in a pure nitrogen gas atmosphere and anhydrous tetrahydrofuran (THF) was added thereto. One equivalent of butyl lithium was added to the reaction vessel in a pure nitrogen atmosphere dried at −78 ° C., and then 1.1 equivalent of paratoluenesulfonyl chloride was added at a time. The reaction was continued for 3 hours at the same temperature. After completion of the reaction by adding sodium chloride, the mixture was extracted with diethyl ether and dried over magnesium sulfate (MgSO 4 ). The solvent was distilled under reduced pressure, and then purified by silica gel chromatography (SiO 2 ) to synthesize a compound of Chemical Formula 5.

수율: 74%Yield: 74%

TLC, Rf 0.4 (5:1 Hexanes/EtOAc) TLC, R f 0.4 (5: 1 Hexanes / EtOAc)

IR (film): 3068, 2953, 2887, 1639, 1598 cm-1 IR (film): 3068, 2953, 2887, 1639, 1598 cm -1

1H NMR (300MHz, CDCl3): δ 2.45 (s, 3H), 4.52 (dt, J = 6.9 , 1.2 Hz, 1H), 5.92 (dt, J = 13.5, 6.9 Hz, 1H), 6.30 (d, J = 13.5 Hz, 1H), 7.36 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 8.4 Hz, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.45 (s, 3H), 4.52 (dt, J = 6.9, 1.2 Hz, 1H), 5.92 (dt, J = 13.5, 6.9 Hz, 1H), 6.30 (d, J = 13.5 Hz, 1H), 7.36 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 8.4 Hz, 2H)

13C NMR (75MHz, CDCl3): δ 21.8, 67.8, 125. 5, 125.8, 128.0, 130.1, 133.1, 145.3 13 C NMR (75 MHz, CDCl 3 ): δ 21.8, 67.8, 12.5, 125.8, 128.0, 130.1, 133.1, 145.3

MS m/z (%) 246 (M+)
MS m / z (%) 246 (M +)

실시예Example 1-2: ( 1-2: ( ZZ )-3-) -3- 클로로알릴Chloroallyl -4--4- 메틸벤젠설포네이트의Of methylbenzenesulfonate 합성 synthesis

[화학식 6] [Formula 6]

Figure 112010054670377-pat00032
Figure 112010054670377-pat00032

위 화합물은 (Z)-3-클로로알릴-2-프로펜-1-올로부터 실시예 1-1과 동일한 방법으로 합성하였다. The above compound was synthesized in the same manner as in Example 1-1 from (Z) -3-chloroallyl-2-propen-1-ol.

수율: 67%Yield: 67%

TLC, Rf 0.4 (5:1 Hexanes/EtOAc) TLC, R f 0.4 (5: 1 Hexanes / EtOAc)

IR(film): 3090, 6055, 2926, 1633, 1597cm -1 IR (film): 3090, 6055, 2926, 1633, 1597 cm -1

1H NMR (300MHz, CDCl3): δ 2.45 (s, 3H), 4.74(dd, J = 6.3, 1.5 Hz, 2H), 5.88 (dt, J = 7.5, 6.3 Hz, 1H), 6.21 (d, J = 7.5 Hz, 1H), 7.35 (d, J = 8.1 Hz, 2H), 7.8 0 (d, J = 8.1 Hz, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.45 (s, 3H), 4.74 (dd, J = 6.3, 1.5 Hz, 2H), 5.88 (dt, J = 7.5, 6.3 Hz, 1H), 6.21 (d, J = 7.5 Hz, 1H), 7.35 (d, J = 8.1 Hz, 2H), 7.8 0 (d, J = 8.1 Hz, 2H)

13C NMR (75MHz, CDCl3): δ 21.8, 65.1, 123.6, 124.6, 128.1, 130.0, 132.9, 145.2 13 C NMR (75 MHz, CDCl 3 ): δ 21.8, 65.1, 123.6, 124.6, 128.1, 130.0, 132.9, 145.2

MS m/z (%) 246 (M+)
MS m / z (%) 246 (M +)

실시예Example 1-3: (E)-1-(3- 1-3: (E) -1- (3- 클로로알릴Chloroallyl )-) - 테트라하이드로Tetrahydro -1H--1H- 사이오페늄Thiophenium 4- 4- 메틸벤젠설포네이트의Of methylbenzenesulfonate 합성  synthesis

[화학식 8][Formula 8]

Figure 112010054670377-pat00033
Figure 112010054670377-pat00033

화학식 5의 화합물 1 당량을 건조된 반응 용기에 넣은 후에 무수 에테르(Et2O)를 가하였다. 그 다음, 건조된 질소 분위기 하에서 화학식 7의 화합물 3 당량을 가하였다. 약 12시간 정도 상온(20℃)에서 반응시킨 결과 하얀색 염이 형성되었고 용매를 따라낸 다음 무수 에테르를 가하였다. 다시 에테르를 제거한 후 감압하여 건조시켰다. 이 결과 매우 높은 순도의 (E)-1-(3-클로로알릴)-테트라하이드로-1H-사이오페늄 4-메틸벤젠설포네이트를 얻었다. One equivalent of compound of formula 5 was added to a dried reaction vessel, followed by addition of anhydrous ether (Et 2 O). Then 3 equivalents of compound of formula 7 were added under a dry nitrogen atmosphere. After reacting at room temperature (20 ° C.) for about 12 hours, a white salt was formed. The solvent was decanted and anhydrous ether was added thereto. The ether was removed again and dried under reduced pressure. As a result, very high purity (E) -1- (3-chloroal ¦´) -tetrahydro-1H-thiophenium 4-methylbenzenesulfonate was obtained.

수율: 76%Yield: 76%

IR(film): 3452, 3058, 2979, 29 50, 2236cm-1 IR (film): 3452, 3058, 2979, 29 50, 2236 cm -1

1H NMR (300MHz, CDCl3): δ 1.93-2.35 (m, 4H), 2.33 (s, 3H), 3.47-3.53 (m, 2H), 3.63-3.72 (m, 2H), 4.42(d, J = 8.1 Hz, 2H), 5.89 (dt, J = 13.2 , 8.1 Hz, 1H), 6.77 (d, J = 13.2 Hz, 1H), 7.15 (d, J = 8.1 Hz, 2H), 7.67 (d, J = 8.1 Hz, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.93-2.35 (m, 4H), 2.33 (s, 3H), 3.47-3.53 (m, 2H), 3.63-3.72 (m, 2H), 4.42 (d, J = 8.1 Hz, 2H), 5.89 (dt, J = 13.2, 8.1 Hz, 1H), 6.77 (d, J = 13.2 Hz, 1H), 7.15 (d, J = 8.1 Hz, 2H), 7.67 (d, J = 8.1 Hz, 2H)

13C NMR (75MHz, CDCl3): δ21.1, 28.7, 41.7, 42.3, 120.7, 125.4, 128.7, 129.8, 13 9.5, 143.5
13 C NMR (75 MHz, CDCl 3 ): δ 21.1, 28.7, 41.7, 42.3, 120.7, 125.4, 128.7, 129.8, 13 9.5, 143.5

실시예Example 1-4: ( 1-4: ( ZZ )-1-(3-) -1- (3- 클로로알릴Chloroallyl )-) - 테트라하이드로Tetrahydro -1H--1H- 사이오페늄Thiophenium 4- 4- 메틸벤젠설포네이트의Of methylbenzenesulfonate 화합물의 합성 Synthesis of compounds

[화학식 9][Chemical Formula 9]

Figure 112010054670377-pat00034
Figure 112010054670377-pat00034

위 화합물은 (Z)-1-(3-클로로알릴)-테트라 하이드로-1H-사이오페늄 4-메틸벤젠설포네이트(화학식 6의 화합물)로부터 실시예 1-3과 동일한 방법을 통해 합성하였다. The above compound was synthesized in the same manner as in Example 1-3 from ( Z ) -1- (3-chloroallyl) -tetra hydro-1H-thiophenium 4-methylbenzenesulfonate (compound of Formula 6).

수율: 75%Yield: 75%

IR(film): 3461, 3300, 3195, 3050, 2983, 2948, 2235, 1625cm-1 IR (film): 3461, 3300, 3195, 3050, 2983, 2948, 2235, 1625 cm -1

1H NMR (300MHz, CDCl3): δ 2.06-2.36 (4H, m), 2.34 (s, 3H), 3.47-3.56 (m, 2H), 3.79-3.88 (m, 2H), 4.30 (d, J = 7.5 Hz, 2H), 6.19 (dt, J = 7.5, 7.5 Hz, 1H), 6.53 (d, 1H, J = 8.1 Hz, 1H), 7.15 (d, 2H, J = 8.1 Hz, 2H), 7.73 (d, 2H, J = 8.1 Hz, 2H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.06-2.36 (4H, m), 2.34 (s, 3H), 3.47-3.56 (m, 2H), 3.79-3.88 (m, 2H), 4.30 (d, J = 7.5 Hz, 2H), 6.19 (dt, J = 7.5, 7.5 Hz, 1H), 6.53 (d, 1H, J = 8.1 Hz, 1H), 7.15 (d, 2H, J = 8.1 Hz, 2H), 7.73 (d, 2H, J = 8.1 Hz, 2H)

13C NMR (75MHz, CDCl3): δ 21.2, 28.8, 38.0, 43.1, 120.0, 125.6, 128.3, 128.7, 139.4, 143.6 13 C NMR (75 MHz, CDCl 3 ): δ 21.2, 28.8, 38.0, 43.1, 120.0, 125.6, 128.3, 128.7, 139.4, 143.6

실시예Example 2:  2: 비닐클로로하이드린Vinylchlorohydrin 유도체의 제조  Preparation of Derivatives

실시예Example 2-1: (+)-(3S,4R)-4- 2-1: (+)-(3S, 4R) -4- 클로로Chloro -1--One- 페닐헥스Phenylhex -5-엔-3-올의 합성Synthesis of -5-en-3-ol

Figure 112010054670377-pat00035
Figure 112010054670377-pat00035

화학식 11의 화합물 (R,R)-비스설폰아미드 1당량이 있는 플라스크에 건조 질소 분위기 하에서 톨루엔을 가하였다. 여기에 화학식 12의 화합물 보란(BH3·SMe2) 3 당량을 가한 다음 서서히 온도를 80℃로 증가시켰다. 20시간 경과 후에 Schlenk를 이용하여 공기 접촉 없이 1 mmHg에서 감압 증류하여 화학식 13의 화합물 카이랄 보란을 얻었다. 이는 NMR을 통해 확인할 수 있다.Toluene was added to a flask with one equivalent of the compound of formula 11 (R, R) -bissulfonamide under a dry nitrogen atmosphere. To this was added 3 equivalents of the compound borane (BH 3 · SMe 2 ) of Formula 12, and then gradually increased the temperature to 80 ° C. After 20 hours, the compound chiral borane of Chemical Formula 13 was obtained by distillation under reduced pressure at 1 mmHg without air contact using Schlenk. This can be confirmed by NMR.

여기에 무수 테트라하이드로퓨란(THF)를 가하여 녹인 다음 바로 다음반응에 사용하였다. 화학식 8의 (E)-설포늄이온 1 당량을 테트라하이드로퓨란(THF)에 녹인 다음 -40℃로 온도를 낮추고 여기에 1.0 M 메틸리튬(MeLi) 1.1 당량을 용기 벽면을 통하여 가하였다. 10분 후, 위에서 합성한 화학식 13의 카이랄 보란을 첨가하였다. 2시간 동안 반응온도 -40℃에서 반응을 시킨 후, 서서히 0℃까지 온도를 상승시켰다. 1시간 경과 후 반응혼합물을 -78℃로 낮춘 다음 화학식 14의 하이드로신남알데히드(R= PhCH2CH2) 1 당량을 가하여 (+)-(3S,4R)-4-클로로-1-페닐-5-헥센-3-올(R = PhCH2CH2)을 얻었다.Anhydrous tetrahydrofuran (THF) was added thereto to dissolve and used for the next reaction. One equivalent of ( E ) -sulfonium ion of Chemical Formula 8 was dissolved in tetrahydrofuran (THF), and then the temperature was lowered to −40 ° C., and 1.1 equivalent of 1.0 M methyllithium (MeLi) was added to the vessel wall. After 10 minutes, chiral borane of formula 13 synthesized above was added. After reacting at -40 ° C for 2 hours, the temperature was gradually raised to 0 ° C. After 1 hour, the reaction mixture was lowered to -78 ° C, and then 1 equivalent of hydrocinnamaldehyde (R = PhCH 2 CH 2 ) of Formula 14 was added (+)-(3S, 4R) -4-chloro-1-phenyl-5 -Hexene-3-ol (R = PhCH 2 CH 2 ) was obtained.

수율: 93%Yield: 93%

[a]D 20 +3.051° (c 1.56, CHCl3) [a] D 20 + 3.051 ° (c 1.56, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc); IR(film): 3431, 3025, 2924, 1602, 1453 cm-1 TLC, R f 0.5 (3: 1 Hexanes / EtOAc); IR (film): 3431, 3025, 2924, 1602, 1453 cm -1

1H NMR (300MHz, CDCl3): δ 1.77-1.85 (m, 2H), 2.15 (d, J = 4.5 Hz, 1H), 2.64-2.74 (m, 1H), 2.84-2.93 (m, 1H), 3.76-3.83 (m, 1H), 4.38 (dd, J = 3.9, 9.0 Hz, 1H), 5.25 (dd, J = 10.2, 1.0 Hz, 1H), 5.35 (dd, J = 17.5, 1.0 Hz, 1H), 5.9 (ddd, J = 17.5, 10.2, 9.0 Hz, 1H), 7.19-7.29 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.77-1.85 (m, 2H), 2.15 (d, J = 4.5 Hz, 1H), 2.64-2.74 (m, 1H), 2.84-2.93 (m, 1H), 3.76-3.83 (m, 1H), 4.38 (dd, J = 3.9, 9.0 Hz, 1H), 5.25 (dd, J = 10.2, 1.0 Hz, 1H), 5.35 (dd, J = 17.5, 1.0 Hz, 1H) , 5.9 (ddd, J = 17.5, 10.2, 9.0 Hz, 1H), 7.19-7.29 (m, 5H)

13C NMR (75MHz, CDCl3): δ 32.2, 34.9, 68.0, 73.7, 120.0, 126.3, 128.7, 128.7, 134.0, 141.7 13 C NMR (75 MHz, CDCl 3 ): δ 32.2, 34.9, 68.0, 73.7, 120.0, 126.3, 128.7, 128.7, 134.0, 141.7

MS m/z (%) 210 (M+)
MS m / z (%) 210 (M +)

실시예Example 2-2: (+)-(1S,2R)-2- 2-2: (+)-(1S, 2R) -2- 클로로Chloro -1--One- 페닐Phenyl -3--3- 부텐Butene -1-올의 합성Synthesis of -1-ol

Figure 112010054670377-pat00036
Figure 112010054670377-pat00036

위 화합물은 실시예 2-1과 동일한 방법(단, 알데히드의 R = Ph)을 이용하여 얻었다.The above compound was obtained using the same method as Example 2-1 (wherein R = Ph of aldehyde).

수율: 72%Yield: 72%

[a]D 20 +2.2° (c 0.2, CHCl3) [a] D 20 + 2.2 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc)TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3355, 2958, 2361, 1460, 1083 cm-1 IR (film): 3355, 2958, 2361, 1460, 1083 cm -1

1H NMR (300MHz, CDCl3): δ 2.53 (d, J = 3.6 Hz, 1H), 4.58 (dd, J = 8.7, 4.2 Hz, 1H), 4.95 (dd, J= 4.2, 3.6 Hz, 1H), 5.23 (d, J = 10.2 Hz,1H), 5.25 (d J = 16.8 Hz, 1H,), 5.93 (ddd, J = 16.8, 10.2, 8.7 Hz, 1H), 7.28-7.37 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.53 (d, J = 3.6 Hz, 1H), 4.58 (dd, J = 8.7, 4.2 Hz, 1H), 4.95 (dd, J = 4.2, 3.6 Hz, 1H) , 5.23 (d, J = 10.2 Hz, 1H), 5.25 (d J = 16.8 Hz, 1H,), 5.93 (ddd, J = 16.8, 10.2, 8.7 Hz, 1H), 7.28-7.37 (m, 5H)

13C NMR (75MHz, CDCl3): δ 67.6, 77.6, 120.3, 126.9, 128.5, 128.6, 133.5, 139.3 13 C NMR (75 MHz, CDCl 3 ): δ 67.6, 77.6, 120.3, 126.9, 128.5, 128.6, 133.5, 139.3

MS m/z (%) 182 (M+)
MS m / z (%) 182 (M +)

실시예Example 2-3:(+)-(3S,4R,E)-4- 2-3: (+)-(3S, 4R, E) -4- 클로로Chloro -1--One- 페닐Phenyl -1,5--1,5- 헥사다이엔Hexadiene -3-올의 합성Synthesis of 3-ol

Figure 112010054670377-pat00037
Figure 112010054670377-pat00037

위 화합물은 실시예 2-1과 동일한 방법(단, 알데히드의 R = PhCH=CH)을 이용하여 얻었다.The above compound was obtained using the same method as Example 2-1 (wherein R = PhCH = CH of aldehyde).

수율: 62%Yield: 62%

[a]D 20 +5.71°(c 0.6, CHCl3) [a] D 20 + 5.71 ° (c 0.6, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc) TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3399, 3027, 1649, 746 cm-1 IR (film): 3399, 3027, 1649, 746 cm -1

1H NMR (300MHz, CDCl3): δ 2.39 (d, J = 4.8 Hz, 1H), 4.49-4.56 (m, 2H), 5.32 (d, J = 10.2 Hz, 1H), 5.41 (d, J = 16.2 Hz, 1H), 5.98 (ddd, J = 16.2, 10.2, 8.4 Hz, 1H), 6.23 (dd, J = 16.2, 6.6 Hz, 1H), 6.70 (d, J = 16.2 Hz, 1H), 7.24-7.39 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.39 (d, J = 4.8 Hz, 1H), 4.49-4.56 (m, 2H), 5.32 (d, J = 10.2 Hz, 1H), 5.41 (d, J = 16.2 Hz, 1H), 5.98 (ddd, J = 16.2, 10.2, 8.4 Hz, 1H), 6.23 (dd, J = 16.2, 6.6 Hz, 1H), 6.70 (d, J = 16.2 Hz, 1H), 7.24- 7.39 (m, 5 H)

13C NMR (75MHz, CDCl3): δ 67.4, 75.6, 120.1, 126.6, 126.9, 128.4, 128.9, 133.8, 134.1, 136.4 13 C NMR (75 MHz, CDCl 3 ): δ 67.4, 75.6, 120.1, 126.6, 126.9, 128.4, 128.9, 133.8, 134.1, 136.4

MS m/z (%) 208 (M+)
MS m / z (%) 208 (M +)

실시예Example 2-4: (+)-(3S,4R)-4- 2-4: (+)-(3S, 4R) -4- 클로로Chloro -1--One- 페닐Phenyl -5--5- 헥센Hexen -1-인-3-올의 합성Synthesis of -1-yn-3-ol

Figure 112010054670377-pat00038
Figure 112010054670377-pat00038

위 화합물은 실시예 2-1과 동일한 방법(단, 알데히드의 R = PhC≡C)을 이용하여 얻었다.The above compound was obtained in the same manner as in Example 2-1, except that R = PhC≡C of aldehyde.

수율: 58%Yield: 58%

[α]D 20 +7.058° (c 1.2, CHCl3) [a] D 2 ° + 7.058 ° (c 1.2, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc)TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3375, 3018, 2929, 2861, 2238 cm-1 IR (film): 3375, 3018, 2929, 2861, 2238 cm -1

1H NMR (300MHz, CDCl3): δ 2.58 (d, J = 8.1 Hz, 1H), 4.61 (dd, J = 8.1, 3.4 Hz, 1H), 4.77 (dd, J = 8.1, 3.4 Hz, 1H), 5.37 (d, J = 10.2 Hz, 1H), 5.49 (d, J = 17.1 Hz, 1H), 6.08 (ddd, J = 17.1, 10.2, 8.1 Hz, 1H), 7.31-7.47 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.58 (d, J = 8.1 Hz, 1H), 4.61 (dd, J = 8.1, 3.4 Hz, 1H), 4.77 (dd, J = 8.1, 3.4 Hz, 1H) , 5.37 (d, J = 10.2 Hz, 1H), 5.49 (d, J = 17.1 Hz, 1H), 6.08 (ddd, J = 17.1, 10.2, 8.1 Hz, 1H), 7.31-7.47 (m, 5H)

13C NMR (75MHz, CDCl3): δ 66.5, 66.5, 85.4, 87.2, 120.3, 122.0, 128.5, 129.0, 132.0, 133.7 13 C NMR (75 MHz, CDCl 3 ): δ 66.5, 66.5, 85.4, 87.2, 120.3, 122.0, 128.5, 129.0, 132.0, 133.7

MS m/z (%) 206 (M+)
MS m / z (%) 206 (M +)

실시예Example 2-5: (+)-(2S,3R)-3- 2-5: (+)-(2S, 3R) -3- 클로로Chloro -1--One- 페닐Phenyl -4--4- 펜텐Pentene -2-올의 합성Synthesis of 2-ol

Figure 112010054670377-pat00039
Figure 112010054670377-pat00039

위 화합물은 실시예 2-1과 동일한 방법(단, 알데히드의 R = PhCH2)을 이용하여 얻었다.The above compound was obtained using the same method as Example 2-1 (wherein R = PhCH 2 of aldehyde).

수율: 67%Yield: 67%

[a]D 20 +13.20°(c 0.2, CHCl3) [a] D 20 + 13.20 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc) TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3431, 3062, 2923, 1602, 1280, 701 cm-1 IR (film): 3431, 3062, 2923, 1602, 1280, 701 cm -1

1H NMR (300MHz, CDCl3): δ 2.06 (s, 1H), 2.78-2.92 (m, 2H), 4.03-4.08 (m, 1H), 4.38 (dd, J = 9.0, 4.2 Hz, 1H), 5.36 (d, J = 9.9 Hz, 1H), 5.39 (d, J = 17.1 Hz, 1H), 6.04 (ddd, J = 17.2, 9.9, 9.0 Hz, 1H), 7.23-7.36 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.06 (s, 1H), 2.78-2.92 (m, 2H), 4.03-4.08 (m, 1H), 4.38 (dd, J = 9.0, 4.2 Hz, 1H), 5.36 (d, J = 9.9 Hz, 1H), 5.39 (d, J = 17.1 Hz, 1H), 6.04 (ddd, J = 17.2, 9.9, 9.0 Hz, 1H), 7.23-7.36 (m, 5H)

13C NMR (75MHz, CDCl3) δ= 39.6, 66.6, 75.6, 120.3, 126.9, 128.8, 129.6, 134.0, 137.5 13 C NMR (75 MHz, CDCl 3 ) δ = 39.6, 66.6, 75.6, 120.3, 126.9, 128.8, 129.6, 134.0, 137.5

MS m/z (%) 196 (M+)
MS m / z (%) 196 (M +)

실시예Example 2-6:(+)-(1S,2R)-2- 2-6: (+)-(1S, 2R) -2- 클로로Chloro -1--One- 시클로헥실Cyclohexyl -3--3- 부텐Butene -1-올의 합성Synthesis of -1-ol

Figure 112010054670377-pat00040
Figure 112010054670377-pat00040

위 화합물은 실시예 2-1과 동일한 방법(단, 알데히드의 R = 사이클로헥실)을 이용하여 얻었다.The above compound was obtained in the same manner as in Example 2-1, except that R = cyclohexyl of aldehyde.

수율: 76%Yield: 76%

[α]D 20 +97.50° (c 0.2, CHCl3) [α] D 20 + 97.50 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc)TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3435, 2925, 2852, 1637, 1448, 1089 cm-1 IR (film): 3435, 2925, 2852, 1637, 1448, 1089 cm -1

1H NMR (300MHz, CDCl3): δ 0.99-2.03 (m, 11H), 2.10 (d, J = 3.3 Hz, 1H), 3.48-3.53 (m, 1H), 4.55 (dd, J = 9.0, 3.9 Hz, 1H), 5.30 (d, J = 9.9 Hz, 1H), 5.36 (d, J = 17.1 Hz, 1H), 6.02 (ddd, J = 17.1, 9.9, 9.3 Hz, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.99-2.03 (m, 11H), 2.10 (d, J = 3.3 Hz, 1H), 3.48-3.53 (m, 1H), 4.55 (dd, J = 9.0, 3.9 Hz, 1H), 5.30 (d, J = 9.9 Hz, 1H), 5.36 (d, J = 17.1 Hz, 1H), 6.02 (ddd, J = 17.1, 9.9, 9.3 Hz, 1H)

13C NMR (75MHz, CDCl3): δ 25.9, 26.1, 26.5, 28.7, 29.1, 40.0, 65.9, 78.5, 119.8, 134.0 13 C NMR (75 MHz, CDCl 3 ): δ 25.9, 26.1, 26.5, 28.7, 29.1, 40.0, 65.9, 78.5, 119.8, 134.0

MS m/z (%) 188 (M+)
MS m / z (%) 188 (M +)

실시예Example 2-7: (-)-(3S,4S)-4- 2-7: (-)-(3S, 4S) -4- 클로로Chloro -1--One- 페닐Phenyl -5--5- 헥센Hexen -3-올의 합성Synthesis of 3-ol

Figure 112010054670377-pat00041
Figure 112010054670377-pat00041

위 화합물은 화학식 8의 (E)-설포늄이온 대신 화학식 9의 화합물 (Z)-설포늄이온을 사용한 것을 제외하고는 실시예 2-1과 동일한 방법(단, 알데히드의 R = PhCH2CH2)을 이용하여 얻었다.The above compound is the same method as Example 2-1 except for using the compound (Z) -sulfonium ion of Formula 9 instead of (E) -sulfonium ion of Formula 8, except that R = PhCH 2 CH 2 of aldehyde ) Was obtained.

수율: 71% Yield: 71%

[α]D 20 -8.80° (c 0.1, CHCl3) [α] D 20 -8.80 ° (c 0.1, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc) TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3573, 3055, 1601, 1264, 738 cm-1 IR (film): 3573, 3055, 1601, 1264, 738 cm -1

1H NMR (300MHz, CDCl3): δ 1.73-1.95 (m, 2H), 2.22 (d, J = 5.4 Hz, 1H), 2.66-3.00 (m, 2H), 3.63-3.71 (m, 1H), 4.38 (dd, J = 8.7, 6.0 Hz, 1H), 5.31 (d, J = 10.2 Hz, 1H), 5.36(d, J = 16.8 Hz, 1H), 5.90 (ddd, J = 16.8, 10.2, 8.7 Hz, 1H), 7.15-7.18 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.73-1.95 (m, 2H), 2.22 (d, J = 5.4 Hz, 1H), 2.66-3.00 (m, 2H), 3.63-3.71 (m, 1H), 4.38 (dd, J = 8.7, 6.0 Hz, 1H), 5.31 (d, J = 10.2 Hz, 1H), 5.36 (d, J = 16.8 Hz, 1H), 5.90 (ddd, J = 16.8, 10.2, 8.7 Hz , 1H), 7.15-7.18 (m, 5H)

13C NMR (75MHz, CDCl3): δ 32.0, 35.6, 69.3, 73.6, 119.54, 126.2, 128.7, 128.7, 135.2, 141.7 13 C NMR (75 MHz, CDCl 3 ): δ 32.0, 35.6, 69.3, 73.6, 119.54, 126.2, 128.7, 128.7, 135.2, 141.7

MS m/z (%)210 (M+)
MS m / z (%) 210 (M +)

실시예Example 2-8: (-)-(1S,2S)-2- 2-8: (-)-(1S, 2S) -2- 클로로Chloro -1--One- 페닐Phenyl -3--3- 부텐Butene -1-올의 합성Synthesis of -1-ol

Figure 112010054670377-pat00042
Figure 112010054670377-pat00042

위 화합물은 실시예 2-7과 동일한 방법(단 RCHO, R = Ph)을 이용하여 얻었다.The above compound was obtained using the same method as in Example 2-7 (RCHO, R = Ph).

수율: 64%Yield: 64%

[α]D 20 -9.21° (c 0.6, CHCl3) [α] D 20 -9.21 ° (c 0.6, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc)TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3437, 3031, 2891, 1638, 1453 cm-1 IR (film): 3437, 3031, 2891, 1638, 1453 cm-1

1H NMR (300MHz, CDCl3): δ 2.82 (d, J = 3.6 Hz, 1H), 4.57 (dd, J = 8.1, 7.5 Hz, 1H), 4.95 (dd, J = 7.5, 3.6 Hz, 1H), 5.13 (d, J = 10.2 Hz, 1H), 5.21 (d, J = 16.8 Hz, 1H), 5.81 (ddd, J = 16.8, 10.2, 8.1 Hz, 1H), 7.26-7.37 (m, 5H) 1 H NMR (300 MHz, CDCl 3): δ 2.82 (d, J = 3.6 Hz, 1H), 4.57 (dd, J = 8.1, 7.5 Hz, 1H), 4.95 (dd, J = 7.5, 3.6 Hz, 1H), 5.13 (d, J = 10.2 Hz, 1H), 5.21 (d, J = 16.8 Hz, 1H), 5.81 (ddd, J = 16.8, 10.2, 8.1 Hz, 1H), 7.26-7.37 (m, 5H)

13C NMR (75MHz, CDCl3): δ 66.6, 77.7, 119.7, 127.2, 128.6, 128.7, 134.4, 139.3 13 C NMR (75 MHz, CDCl 3 ): δ 66.6, 77.7, 119.7, 127.2, 128.6, 128.7, 134.4, 139.3

MS m/z (%) 182 (M+)
MS m / z (%) 182 (M +)

실시예Example 2-9: (-)-(3S,4S,E)-4- 2-9: (-)-(3S, 4S, E) -4- 클로로Chloro -1--One- 페닐Phenyl -1,5--1,5- 헥사다이엔Hexadiene -3-올의 합성Synthesis of 3-ol

Figure 112010054670377-pat00043
Figure 112010054670377-pat00043

위 화합물은 실시예 2-7과 동일한 방법(단, 알데히드의 R = PhCH=CH)을 이용하여 얻었다.The above compound was obtained using the same method as Example 2-7 (wherein R = PhCH = CH of aldehyde).

수율: 50%Yield: 50%

[α]D 20 -10.32° (c 0.2, CHCl3) [α] D 20 -10.32 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc)TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3392, 3083, 2952, 2851, 1448 cm-1 IR (film): 3392, 3083, 2952, 2851, 1448 cm -1

1H NMR (300MHz, CDCl3): δ 2.45 (d, J = 4.8 Hz, 1H), 4.38-4.47 (m, 2H), 5.30 (d, J = 10.2 Hz, 1H), 5.42 (d, J = 15.9 Hz, 1H), 5.98 (ddd, J = 15.9, 10.2, 8.1 Hz, 1H), 6.22 (dd, J = 15.9, 5.7 Hz, 1H), 6.72 (d, J = 15.9 Hz, 1H), 7.25-7.42(m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.45 (d, J = 4.8 Hz, 1H), 4.38-4.47 (m, 2H), 5.30 (d, J = 10.2 Hz, 1H), 5.42 (d, J = 15.9 Hz, 1H), 5.98 (ddd, J = 15.9, 10.2, 8.1 Hz, 1H), 6.22 (dd, J = 15.9, 5.7 Hz, 1H), 6.72 (d, J = 15.9 Hz, 1H), 7.25- 7.42 (m, 5 H)

13C NMR (75MHz, CDCl3) δ 68.0, 75.4, 119.9, 126.9, 127.0, 128.3, 128.8, 133.3, 134.7, 136.4 13 C NMR (75 MHz, CDCl 3 ) δ 68.0, 75.4, 119.9, 126.9, 127.0, 128.3, 128.8, 133.3, 134.7, 136.4

MS m/z (%) 208 (M+)
MS m / z (%) 208 (M +)

실시예Example 2-10: (-)-(3S,4S)-4- 2-10: (-)-(3S, 4S) -4- 클로로Chloro -1--One- 페닐Phenyl -5--5- 헥센Hexen -1-인-3-올의 합성Synthesis of -1-yn-3-ol

Figure 112010054670377-pat00044
Figure 112010054670377-pat00044

위 화합물은 실시예 2-7과 동일한 방법(단, 알데히드의 R = PhC≡C)을 이용하여 얻었다.The above compound was obtained in the same manner as in Example 2-7, except that R = PhC≡C of aldehyde.

수율: 51%Yield: 51%

[α]D 20 -2.337° (c 0.95, CHCl3) [α] D 20 -2.337 ° (c 0.95, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc) TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3381, 3062, 2924, 2236 cm-1 IR (film): 3381, 3062, 2924, 2236 cm -1

1H NMR (300MHz, CDCl3): δ 2.50 (S, 1H), 4.53 (dd, J = 8.4, 5.4 Hz, 1H), 4.72 (d, J = 5.4 Hz, 1H), 5.38 (d, J = 10.2 Hz, 1H), 5.49 (d, J = 17.1 Hz, 1H), 6.08 (ddd, J = 17.1, 10.2, 8.4 Hz, 1H), 7.31-7.47 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.50 (S, 1H), 4.53 (dd, J = 8.4, 5.4 Hz, 1H), 4.72 (d, J = 5.4 Hz, 1H), 5.38 (d, J = 10.2 Hz, 1H), 5.49 (d, J = 17.1 Hz, 1H), 6.08 (ddd, J = 17.1, 10.2, 8.4 Hz, 1H), 7.31-7.47 (m, 5H)

13C NMR (75MHz, CDCl3): δ 66.0, 66.7, 85.8, 87.2, 120.6, 122.1, 128.5, 129.1, 132.0, 134.0 13 C NMR (75 MHz, CDCl 3 ): δ 66.0, 66.7, 85.8, 87.2, 120.6, 122.1, 128.5, 129.1, 132.0, 134.0

MS m/z (%) 206 (M+)
MS m / z (%) 206 (M +)

실시예Example 2-11: (-)-(2S,3S)-3- 2-11: (-)-(2S, 3S) -3- 클로로Chloro -1--One- 페닐Phenyl -4--4- 펜텐Pentene -2-올의 합성Synthesis of 2-ol

Figure 112010054670377-pat00045
Figure 112010054670377-pat00045

위 화합물은 실시예 2-7과 동일한 방법(단, 알데히드의 R = PhCH2)을 이용하여 얻었다.The above compound was obtained using the same method as Example 2-7 (wherein R = PhCH 2 of aldehyde).

수율: 51%Yield: 51%

[α]D 20 -5.565° (c 0.575, CHCl3) [α] D 20 -5.565 ° (c 0.575, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc)TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3419, 3027, 2923, 1603, 700 cm-1 IR (film): 3419, 3027, 2923, 1603, 700 cm -1

1H NMR (300MHz, CDCl3): δ 2.13 (d, J = 6.0 Hz, 1H), 2.77-3.00 (m, 2H), 3.89-3.97 (m, 1H), 4.36 (dd, J = 8.4, 18.4 Hz, 1H), 5.29 (d, J = 10.2 Hz, 1H), 5.37 (d, J = 17.1 Hz, 1H), 6.01 (ddd, J = 17.1, 10.2, 8.4 Hz, 1H), 7.18-7.35 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.13 (d, J = 6.0 Hz, 1H), 2.77-3.00 (m, 2H), 3.89-3.97 (m, 1H), 4.36 (dd, J = 8.4, 18.4 Hz, 1H), 5.29 (d, J = 10.2 Hz, 1H), 5.37 (d, J = 17.1 Hz, 1H), 6.01 (ddd, J = 17.1, 10.2, 8.4 Hz, 1H), 7.18-7.35 (m , 5H)

13C NMR (75MHz, CDCl3): δ 40.4, 67.3, 75.3, 119.4, 126.9, 128.8, 129.6, 135.4, 137.5 13 C NMR (75 MHz, CDCl 3 ): δ 40.4, 67.3, 75.3, 119.4, 126.9, 128.8, 129.6, 135.4, 137.5

MS m/z (%) 196 (M+)
MS m / z (%) 196 (M +)

실시예Example 2-12: (-)-(1S,2S)-2- 2-12: (-)-(1S, 2S) -2- 클로로Chloro -1--One- 시클로헥실Cyclohexyl -3--3- 부텐Butene -1-올의 합성Synthesis of -1-ol

Figure 112010054670377-pat00046
Figure 112010054670377-pat00046

위 화합물은 실시예 2-7과 동일한 방법(단, 알데히드의 R = 사이클로헥실)을 이용하여 얻었다.The above compound was obtained in the same manner as in Example 2-7, except that R = cyclohexyl of aldehyde.

수율: 67%Yield: 67%

[α]D 20 -50.89° (c 0.705, CHCl3) [α] D 20 -50.89 ° (c 0.705, CHCl 3 )

TLC, Rf 0.5 (3:1 Hexanes/EtOAc) TLC, R f 0.5 (3: 1 Hexanes / EtOAc)

IR(film): 3406, 3083, 2926, 1449 cm-1 IR (film): 3406, 3083, 2926, 1449 cm -1

1H NMR (300MHz, CDCl3): δ 1.06-1.85 (m, 11H), 1.97 (d, J = 6.6 Hz, 1H), 3.35-3.40 (m, 1H), 4.55 (dd, J = 9,1, 5.1 Hz, 1H), 5.25 (d, J = 10.2 Hz, 1H), 5.38 (d, J = 16.8 Hz, 1H), 6.00 (ddd, J = 16.8, 10.2, 8.7 Hz, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.06-1.85 (m, 11H), 1.97 (d, J = 6.6 Hz, 1H), 3.35-3.40 (m, 1H), 4.55 (dd, J = 9,1 , 5.1 Hz, 1H), 5.25 (d, J = 10.2 Hz, 1H), 5.38 (d, J = 16.8 Hz, 1H), 6.00 (ddd, J = 16.8, 10.2, 8.7 Hz, 1H)

13C NMR (75MHz, CDCl3): δ 26.1, 26.3, 26.4, 27.3, 29.8, 40.8, 67.2, 78.5, 118.7, 135.9 13 C NMR (75 MHz, CDCl 3 ): δ 26.1, 26.3, 26.4, 27.3, 29.8, 40.8, 67.2, 78.5, 118.7, 135.9

MS m/z (%) 188 (M+)
MS m / z (%) 188 (M +)

실시예Example 3: 비닐  3: vinyl 옥시란Oxirane 유도체의 합성 Synthesis of derivatives

실시예Example 3-1: (-)-(2S,3S)-2- 3-1: (-)-(2S, 3S) -2- 페닐Phenyl -3--3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00047
Figure 112010054670377-pat00047

실시예 2-2에서 얻은 anti-비닐클로로하이드린 유도체(R = Ph) 1당량을 건조된 플라스크에 넣고 디클로로메탄을 넣었다. 실온에서 DBU 3당량을 가한 후 2시간 동안 실온(20℃)에서 반응시킨 후 물을 넣어서 반응을 종결시켰다. 디클로로메탄으로 추출한 후에 황산마그네슘(MgSO4)으로 건조시켰다. 용매를 감압증류한 후에 실리카젤 크로마토그래피로 정제하여 비닐옥시란 유도체인 (-)-(2S,3S)-2-페닐-3-비닐옥시란을 순수한 형태로 얻었다.One equivalent of the anti-vinylchlorohydrin derivative (R = Ph) obtained in Example 2-2 was placed in a dried flask and dichloromethane was added thereto. After adding 3 equivalents of DBU at room temperature and reacting at room temperature (20 ° C.) for 2 hours, water was added to terminate the reaction. After extraction with dichloromethane it was dried over magnesium sulfate (MgSO 4 ). The solvent was distilled under reduced pressure and purified by silica gel chromatography to obtain (-)-(2S, 3S) -2-phenyl-3-vinyloxirane, a vinyloxirane derivative, in pure form.

수율: 75%Yield: 75%

[α]D 20 -43.0° (c 0.2, CHCl3) [α] D 20 -43.0 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc) TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3087, 3033., 2924, 2851, 1639, 1606, 1495, 1458, 1440 cm-1 IR (film): 3087, 3033., 2924, 2851, 1639, 1606, 1495, 1458, 1440 cm -1

1H NMR (300MHz, CDCl3): δ 3.36 (d, J = 7.2 Hz, 1H), 3.76 (S, 1H), 5.33 (d, J = 10.2 Hz, 1H), 5.43 (d, J = 17.4 Hz, 1H), 5.71 (ddd, J = 17.4, 10.2, 7.2 Hz, 1H), 7.37-7.24 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 3.36 (d, J = 7.2 Hz, 1H), 3.76 (S, 1H), 5.33 (d, J = 10.2 Hz, 1H), 5.43 (d, J = 17.4 Hz , 1H), 5.71 (ddd, J = 17.4, 10.2, 7.2 Hz, 1H), 7.37-7.24 (m, 5H)

13C NMR (75MHz, CDCl3): δ 60.4, 63.2, 119.8, 125.7, 128.4, 128.7, 135.3, 137.2 13 C NMR (75 MHz, CDCl 3 ): δ 60.4, 63.2, 119.8, 125.7, 128.4, 128.7, 135.3, 137.2

MS m/z (%) 146 (M+)
MS m / z (%) 146 (M +)

실시예Example 3-2:(-)-(2S,3S,E)-2- 3-2: (-)-(2S, 3S, E) -2- 스티릴Styryl -3--3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00048
Figure 112010054670377-pat00048

위 화합물은 실시예 2-3에서 얻은 anti-비닐클로로하이드린 유도체를 출발물질로 하여 실시예 3-1과 동일한 방법으로 얻었다.The above compound was obtained in the same manner as in Example 3-1, using the anti-vinylchlorohydrin derivative obtained in Example 2-3 as a starting material.

수율: 70%Yield: 70%

[α]D 20 -5.065° (c 1.23, CHCl3) [α] D 20 -5.065 ° (c 1.23, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc)TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3025, 2989, 1682, 1642, 1494, 1450 cm-1 IR (film): 3025, 2989, 1682, 1642, 1494, 1450 cm -1

1H NMR (300MHz, CDCl3): δ 3.38 (d, J = 7.5 Hz, 1H) 3.43 (d, J = 7.5 Hz, 1H), 5.33 (d, J = 9.9 Hz, 1H), 5.52 (d, J = 16.5 Hz, 1H), 5.66 (ddd, J = 16.5, 9.9, 7.5 Hz, 1H), 5.95 (dd, J = 16.5, 7.5 Hz, 1H), 6.79 (d, J = 16.5 Hz, 1H),7.40-7.24 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 3.38 (d, J = 7.5 Hz, 1H) 3.43 (d, J = 7.5 Hz, 1H), 5.33 (d, J = 9.9 Hz, 1H), 5.52 (d, J = 16.5 Hz, 1H), 5.66 (ddd, J = 16.5, 9.9, 7.5 Hz, 1H), 5.95 (dd, J = 16.5, 7.5 Hz, 1H), 6.79 (d, J = 16.5 Hz, 1H), 7.40-7.24 (m, 5H)

13C NMR (75MHz, CDCl3): δ 60.7, 61.0, 119.7, 126.2, 126.3, 128.3, 128.8, 135.2, 136.3, 138.4 13 C NMR (75 MHz, CDCl 3 ): δ 60.7, 61.0, 119.7, 126.2, 126.3, 128.3, 128.8, 135.2, 136.3, 138.4

MS m/z (%) 172 (M+)
MS m / z (%) 172 (M +)

실시예Example 3-3:(-)-(2S,3S)-2-( 3-3: (-)-(2S, 3S) -2- ( 페닐에티닐Phenylethynyl )-3-) -3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00049
Figure 112010054670377-pat00049

위 화합물은 실시예 2-4에서 얻은 anti-비닐클로로하이드린 유도체를 출발물질로 하여 실시예 3-1과 동일한 방법으로 얻었다.The above compound was obtained in the same manner as in Example 3-1, using the anti-vinylchlorohydrin derivative obtained in Example 2-4 as a starting material.

수율: 62% Yield: 62%

(α]D 20 -21.61° (c 0.67, CHCl3) (α) D 20 -21.61 ° (c 0.67, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc) TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3053, 2985, 2304 cm-1 IR (film): 3053, 2985, 2304 cm -1

1H NMR (300MHz, CDCl3): δ 3.48 (d, J = 2.1 Hz, 1H), 3.60-3.63 (m, 1H), 5.36-5.40 (m, 1H), 5.58-5.62 (m, 2H), 7.29-7.47 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 3.48 (d, J = 2.1 Hz, 1H), 3.60-3.63 (m, 1H), 5.36-5.40 (m, 1H), 5.58-5.62 (m, 2H), 7.29-7.47 (m, 5H)

13C NMR (75MHz, CDCl3): δ 47.7, 60.6, 84.2, 85.1, 120.9, 122.0, 128.4, 128.9, 132.0, 134.0 13 C NMR (75 MHz, CDCl 3 ): δ 47.7, 60.6, 84.2, 85.1, 120.9, 122.0, 128.4, 128.9, 132.0, 134.0

MS m/z (%) 170 (M+)
MS m / z (%) 170 (M +)

실시예Example 3-4:(-)-(2S,3S)-2- 3-4: (-)-(2S, 3S) -2- 펜에틸Phenethyl -3--3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00050
Figure 112010054670377-pat00050

위 화합물은 실시예 2-1에서 얻은 anti-비닐클로로하이드린 유도체를 출발물질로 하여 실시예 3-1과 동일한 방법으로 얻었다.The above compound was obtained in the same manner as in Example 3-1 using the anti-vinylchlorohydrin derivative obtained in Example 2-1 as a starting material.

수율: 80%Yield: 80%

[α]D 20 -22.79° (c 2.355, CHCl3) [α] D 20 -22.79 ° (c 2.355, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc)TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3055, 3027, 2959, 2925, 2854, 1601, 1454, 1263 cm-1 IR (film): 3055, 3027, 2959, 2925, 2854, 1601, 1454, 1263 cm -1

1H NMR (300MHz, CDCl3): δ1.85-1.93 (m, 2H), 2.68-2.80 (m, 2H), 2.82-2.88 (m, 1H), 3.05 (d, J = 7.5 Hz, 1H), 5.23 (d, J = 9.9 Hz, 1H), 5.39 (d, J = 17.1 Hz, 1H), 5.54 (ddd, J = 17.1, 9.9, 7.5 Hz, 1H), 7.31-7.18 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.85-1.93 (m, 2H), 2.68-2.80 (m, 2H), 2.82-2.88 (m, 1H), 3.05 (d, J = 7.5 Hz, 1H) , 5.23 (d, J = 9.9 Hz, 1H), 5.39 (d, J = 17.1 Hz, 1H), 5.54 (ddd, J = 17.1, 9.9, 7.5 Hz, 1H), 7.31-7.18 (m, 5H)

13C NMR (75MHz, CDCl3): δ 32.2, 33.8, 58.9, 59.7, 119.1, 126.1, 128.4, 128.5, 135.7, 141.2 13 C NMR (75 MHz, CDCl 3 ): δ 32.2, 33.8, 58.9, 59.7, 119.1, 126.1, 128.4, 128.5, 135.7, 141.2

MS m/z (%) 174 (M+)
MS m / z (%) 174 (M +)

실시예Example 3-5:(+)-(2S,3S)-2-벤질-3- 3-5: (+)-(2S, 3S) -2-benzyl-3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00051
Figure 112010054670377-pat00051

위 화합물은 실시예 2-5에서 얻은 anti-비닐클로로하이드린 유도체를 출발물질로 하여 실시예 3-1과 동일한 방법으로 얻었다.The above compound was obtained in the same manner as in Example 3-1, using the anti-vinylchlorohydrin derivative obtained in Example 2-5 as a starting material.

수율: 75%Yield: 75%

[α]D 20 +2.60° (c 0.2, CHCl3) [α] D 20 + 2.60 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc)TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3027, 2981, 2916, 1642, 1604, 1496, 1453, 1403 cm-1 IR (film): 3027, 2981, 2916, 1642, 1604, 1496, 1453, 1403 cm -1

1H NMR(300MHz, CDCl3): δ 2.86-2.98 (m, 2H), 306-3.11 (m, 1H), 3.19 (d, J = 7.2 Hz, 1H), 5.28 (m, 1H), 5.47 (d, J = 17.1 Hz, 1H), 5.53-5.65 (m, 1H), 7.24-7.35 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.86-2.98 (m, 2H), 306-3.11 (m, 1H), 3.19 (d, J = 7.2 Hz, 1H), 5.28 (m, 1H), 5.47 ( d, J = 17.1 Hz, 1H), 5.53-5.65 (m, 1H), 7.24-7.35 (m, 5H)

13C NMR (75MHz, CDCl3): δ 38.3, 58.7, 60.4, 119.4, 126.8, 128.6, 129.1, 135.4, 137.1 13 C NMR (75 MHz, CDCl 3 ): δ 38.3, 58.7, 60.4, 119.4, 126.8, 128.6, 129.1, 135.4, 137.1

MS m/z (%) 160 (M+)
MS m / z (%) 160 (M +)

실시예Example 3-6:(-)-(2S,3S)-2- 3-6: (-)-(2S, 3S) -2- 시클로헥실Cyclohexyl -3--3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00052
Figure 112010054670377-pat00052

위 화합물은 실시예 2-6에서 얻은 anti-비닐클로로하이드린 유도체를 출발물질로 하여 실시예 3-1과 동일한 방법으로 얻었다.The above compound was obtained in the same manner as in Example 3-1 using the anti-vinylchlorohydrin derivative obtained in Example 2-6 as a starting material.

수율: 70%Yield: 70%

[α]D 20 -8.7° (c 0.2, CHCl3) [α] D 20 -8.7 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc) TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3086, 2924, 2852, 1643, 1451, 1404 cm-1 IR (film): 3086, 2924, 2852, 1643, 1451, 1404 cm -1

1H NMR (300MHz, CDCl3): δ 0.82-1.88 (m, 11H), 2.63 (d, J = 6.6 Hz, 1H), 3.16 (d, J = 7.2Hz, 1H), 5.23 (d, J = 10.2 Hz, 1H), 5.43 (d, J = 17.4 Hz, 1H), 5.58 (ddd, J = 17.4, 10.2, 7.2 Hz, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.82-1.88 (m, 11H), 2.63 (d, J = 6.6 Hz, 1H), 3.16 (d, J = 7.2 Hz, 1H), 5.23 (d, J = 10.2 Hz, 1H), 5.43 (d, J = 17.4 Hz, 1H), 5.58 (ddd, J = 17.4, 10.2, 7.2 Hz, 1H)

13C NMR (75MHz, CDCl3): δ 25.6, 25.8, 26.4, 29.04, 29.6, 40.2, 57.6, 64.8, 118.8, 136.2 13 C NMR (75 MHz, CDCl 3): δ 25.6, 25.8, 26.4, 29.04, 29.6, 40.2, 57.6, 64.8, 118.8, 136.2

MS m/z (%) 152 (M+)
MS m / z (%) 152 (M +)

실시예Example 3-7:(-)-(2S,3R)-2- 3-7: (-)-(2S, 3R) -2- 페닐Phenyl -3--3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00053
Figure 112010054670377-pat00053

실시예 2-8에서 얻은 시스 클로로하이드린 유도체 1 당량을 넣는 것을 제외하고는 실시예 3-1과 동일한 방법으로 위 화합물을 얻었다. The above compound was obtained in the same manner as in Example 3-1, except that 1 equivalent of the cis chlorohydrin derivative obtained in Example 2-8 was added.

수율: 61%Yield: 61%

[α]D 20 -10.57° (c 0.615, CHCl3) [α] D 20 -10.57 ° (c 0.615, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc) TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3086, 3031, 2957, 2924, 2853, 1496, 1453, 1441 cm-1 IR (film): 3086, 3031, 2957, 2924, 2853, 1496, 1453, 1441 cm -1

1H NMR (300MHz, CDCl3): δ 3.68 (dd, J = 7.8, 4.2 Hz, 1H), 4.26 (d, J = 4.2 Hz, 1H), 5.28 (dd, J = 10.2, 1.8 Hz, 1H), 5.40 (ddd, J = 16.8, 10.2, 7.8 Hz, 1H), 5.56 (dd, J = 16.8, 1.8 Hz, 1H), 7.37-7.30 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 3.68 (dd, J = 7.8, 4.2 Hz, 1H), 4.26 (d, J = 4.2 Hz, 1H), 5.28 (dd, J = 10.2, 1.8 Hz, 1H) , 5.40 (ddd, J = 16.8, 10.2, 7.8 Hz, 1H), 5.56 (dd, J = 16.8, 1.8 Hz, 1H), 7.37-7.30 (m, 5H)

13C NMR (75MHz, CDCl3): δ 59.1, 60.0, 122.3, 126.6, 127.9, 128.3, 132.2, 135.3 13 C NMR (75 MHz, CDCl 3 ): δ 59.1, 60.0, 122.3, 126.6, 127.9, 128.3, 132.2, 135.3

MS m/z (%) 146 (M+)
MS m / z (%) 146 (M +)

실시예Example 3-8:(+)-(2S,3R,E)-2- 3-8: (+)-(2S, 3R, E) -2- 스티릴Styryl -3--3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00054
Figure 112010054670377-pat00054

실시예 2-9에서 얻은 시스 클로로하이드린 유도체 1 당량을 넣는 것을 제외하고는 실시예 3-7과 동일한 방법으로 위 화합물을 얻었다.The above compound was obtained in the same manner as in Example 3-7 except that 1 equivalent of the cis chlorohydrin derivative obtained in Example 2-9 was added.

수율: 63%Yield: 63%

[α]D 20 +3.6° (c 0.2, CHCl3) [α] D 2 0 + 3.6 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc)TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR (film):3027, 2954, 2853, 1640, 1494, 1450 cm-1 IR (film): 3027, 2954, 2853, 1640, 1494, 1450 cm -1

1H NMR (300MHz, CDCl3): δ 3.59-3.63 (m, 1H), 3.75 (d, J = 7.2, 4.5Hz, 1H), 5.41 (dd, J = 10.5, 0.9Hz, 1H), 5.57 (dd, J = 15.9, 0.9Hz, 1H), 5.81 (ddd, J = 15.9, 10.5, 7.2Hz, 1H), 6.06 (dd, J = 15.9, 7.8Hz, 1H), 6.83 (d, J = 15.9Hz, 1H), 7.27-7.41 (m, 5H) 1 H NMR (300MHz, CDCl 3 ): δ 3.59-3.63 (m, 1H), 3.75 (d, J = 7.2, 4.5 Hz, 1H), 5.41 (dd, J = 10.5, 0.9 Hz, 1H), 5.57 ( dd, J = 15.9, 0.9 Hz, 1H), 5.81 (ddd, J = 15.9, 10.5, 7.2 Hz, 1H), 6.06 (dd, J = 15.9, 7.8 Hz, 1H), 6.83 (d, J = 15.9 Hz , 1H), 7.27-7.41 (m, 5H)

13C NMR (75MHz, CDCl3): δ 59.2, 59.6, 121.2, 123.5, 126.7, 128.3, 128.8, 132.5, 135.9, 136.3 13 C NMR (75 MHz, CDCl 3 ): δ 59.2, 59.6, 121.2, 123.5, 126.7, 128.3, 128.8, 132.5, 135.9, 136.3

MS m/z (%) 172 (M+)
MS m / z (%) 172 (M +)

실시예Example 3-9:(-)-(2S,3R)-2-( 3-9: (-)-(2S, 3R) -2- ( 페닐에티닐Phenylethynyl )-3-) -3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00055
Figure 112010054670377-pat00055

실시예 2-10에서 얻은 시스 클로로하이드린 유도체 1 당량을 넣는 것을 제외하고는 실시예 3-7과 동일한 방법으로 위 화합물을 얻었다.The above compound was obtained in the same manner as in Example 3-7 except that 1 equivalent of the cis chlorohydrin derivative obtained in Example 2-10 was added.

수율: 60%Yield: 60%

[α]D 20 -24.58° (c 0.45, CHCl3) [α] D 20 -24.58 ° (c 0.45, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc)TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3056, 2956, 2924, 2853, 2225 cm-1 IR (film): 3056, 2956, 2924, 2853, 2225 cm -1

1H NMR (300MHz, CDCl3): δ 3.59 (dd, J = 8.1, 4.0 Hz, 1H), 3.83 (d, J = 4.0 Hz, 1H), 5.5 (dd, J = 10.5, 1.2 Hz, 1H), 5.65 (dd, J = 17.4, 1.2 Hz, 1H), 5.89 (ddd, J = 17.4, 10.5, 8.1 Hz, 1H), 7.27-7.48 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 3.59 (dd, J = 8.1, 4.0 Hz, 1H), 3.83 (d, J = 4.0 Hz, 1H), 5.5 (dd, J = 10.5, 1.2 Hz, 1H) , 5.65 (dd, J = 17.4, 1.2 Hz, 1H), 5.89 (ddd, J = 17.4, 10.5, 8.1 Hz, 1H), 7.27-7.48 (m, 5H)

13C NMR (75MHz, CDCl3): δ 47.0, 58.7, 83.8, 85.8, 122.0, 122.4, 128.4, 128.9, 132.0, 132.9 13 C NMR (75 MHz, CDCl 3 ): δ 47.0, 58.7, 83.8, 85.8, 122.0, 122.4, 128.4, 128.9, 132.0, 132.9

MS m/z (%) 170 (M+)
MS m / z (%) 170 (M +)

실시예Example 3-10:(-)-(2S,3R)-2-( 3-10: (-)-(2S, 3R) -2- ( 페닐에티닐Phenylethynyl )-3-) -3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00056
Figure 112010054670377-pat00056

실시예 2-7에서 얻은 시스 클로로하이드린 유도체 1 당량을 넣는 것을 제외하고는 실시예 3-7과 동일한 방법으로 위 화합물을 얻었다.The above compound was obtained in the same manner as in Example 3-7, except that 1 equivalent of the cis chlorohydrin derivative obtained in Example 2-7 was added.

수율:75%Yield: 75%

[α]D 20 -24.99° (c 1.005, CHCl3) [α] D 20 -24.99 ° (c 1.005, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc)TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3026, 2955, 2924, 2856, 1495, 1453 cm-1 IR (film): 3026, 2955, 2924, 2856, 1495, 1453 cm -1

1H NMR (300MHz, CDCl3): δ 1.75-1.98 (m, 2H), 2.68-2.88 (m, 2H), 3.11-3.17 (m, 1H), 3.43 (dd, J = 7.2, 4.5 Hz, 1H), 5.34 (dd, J = 10.5, 1.5 Hz, 1H), 5.46 (dd, J = 17.1, 1.5 Hz, 1H), 5.68 (ddd, J = 17.1, 10.5, 7.2 Hz, 1H), 7.32-7.18 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.75-1.98 (m, 2H), 2.68-2.88 (m, 2H), 3.11-3.17 (m, 1H), 3.43 (dd, J = 7.2, 4.5 Hz, 1H ), 5.34 (dd, J = 10.5, 1.5 Hz, 1H), 5.46 (dd, J = 17.1, 1.5 Hz, 1H), 5.68 (ddd, J = 17.1, 10.5, 7.2 Hz, 1H), 7.32-7.18 ( m, 5H)

13C NMR (75MHz, CDCl3): δ 29.8, 32.7, 57.5, 58.4, 120.7, 126.3, 128.6, 128.6, 132.4, 141.4 13 C NMR (75 MHz, CDCl 3 ): δ 29.8, 32.7, 57.5, 58.4, 120.7, 126.3, 128.6, 128.6, 132.4, 141.4

MS m/z (%) 174 (M+)
MS m / z (%) 174 (M +)

실시예Example 3-11:(+)-(2S,3R)-2-벤질-3- 3-11: (+)-(2S, 3R) -2-benzyl-3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00057
Figure 112010054670377-pat00057

실시예 2-11에서 얻은 시스 클로로하이드린 유도체 1 당량을 넣는 것을 제외하고는 실시예 3-7과 동일한 방법으로 위 화합물을 얻었다.The above compound was obtained in the same manner as in Example 3-7 except that 1 equivalent of the cis chlorohydrin derivative obtained in Example 2-11 was added.

수율: 71.2%Yield: 71.2%

[α]D 20 +4.522° (c 0.92, CHCl3) [a] D 2 ° + 4.522 ° (c 0.92, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc)TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3086, 3063, 3028, 2922, 2853, 1640, 1496, 1456, 1405 cm-1 IR (film): 3086, 3063, 3028, 2922, 2853, 1640, 1496, 1456, 1405 cm -1

1H NMR (300MHz, CDCl3): δ 2.77-2.99 (m, 2H), 3.29-3.35 (m, 1H), 3.52 (dd, J = 6.9, 4.2 Hz, 1H), 5.45(d, J = 10.5 Hz, 1H), 5.56 (d, J = 16.5 Hz, 1H), 5.89 (ddd, J = 16.5, 10.5, 6.9 Hz, 1H), 7.35-7.24 (m, 5H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.77-2.99 (m, 2H), 3.29-3.35 (m, 1H), 3.52 (dd, J = 6.9, 4.2 Hz, 1H), 5.45 (d, J = 10.5 Hz, 1H), 5.56 (d, J = 16.5 Hz, 1H), 5.89 (ddd, J = 16.5, 10.5, 6.9 Hz, 1H), 7.35-7.24 (m, 5H)

13C NMR (75MHz, CDCl3): δ 34.3, 57.6, 59.3, 121.4, 126.9, 128.8, 129.1, 132.5, 137.7 13 C NMR (75 MHz, CDCl 3 ): δ 34.3, 57.6, 59.3, 121.4, 126.9, 128.8, 129.1, 132.5, 137.7

MS m/z (%) 160 (M+)
MS m / z (%) 160 (M +)

실시예Example 3-12:(-)-(2S,3R)-2- 3-12: (-)-(2S, 3R) -2- 시클로헥실Cyclohexyl -3--3- 비닐옥시란의Vinyloxirane 합성 synthesis

Figure 112010054670377-pat00058
Figure 112010054670377-pat00058

실시예 2-12에서 얻은 시스 클로로하이드린 유도체 1 당량을 넣는 것을 제외하고는 실시예 3-7과 동일한 방법으로 위 화합물을 얻었다.The above compound was obtained in the same manner as in Example 3-7 except that 1 equivalent of the cis chlorohydrin derivative obtained in Example 2-12 was added.

수율: 65%Yield: 65%

[α]D 20 -3.7° (c 0.2, CHCl3) [α] D 20 -3.7 ° (c 0.2, CHCl 3 )

TLC, Rf 0.5 (5:1 Hexanes/EtOAc)TLC, R f 0.5 (5: 1 Hexanes / EtOAc)

IR(film): 3086, 2926, 2851, 1638, 1449, 1413 cm-1 IR (film): 3086, 2926, 2851, 1638, 1449, 1413 cm -1

1H NMR (300MHz, CDCl3): δ 0.86-1.99 (m, 11H), 2.77-2.81(m, 1H), 3.41 (dd, J = 7.5, 4.5 Hz, 1H), 5.35 (dd, J = 10.2, 1.8 Hz, 1H), 5.49 (dd, J = 17.4, 1.8 Hz, 1H), 5.72 (ddd, J = 17.4, 10.2, 7.5 Hz, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 0.86-1.99 (m, 11H), 2.77-2.81 (m, 1H), 3.41 (dd, J = 7.5, 4.5 Hz, 1H), 5.35 (dd, J = 10.2 , 1.8 Hz, 1H), 5.49 (dd, J = 17.4, 1.8 Hz, 1H), 5.72 (ddd, J = 17.4, 10.2, 7.5 Hz, 1H)

13C NMR (75MHz, CDCl3): δ 24.3, 24.4, 25.1, 27.4, 29.6,35.5, 56.2, 62.2, 119.5, 131.7 13 C NMR (75 MHz, CDCl 3 ): δ 24.3, 24.4, 25.1, 27.4, 29.6,35.5, 56.2, 62.2, 119.5, 131.7

MS m/z (%) 152 (M+)
MS m / z (%) 152 (M +)

실시예Example 4:  4: 폰티카에폭사이드(Ponticaepoxide)의Of Ponticaepoxide 합성 synthesis

하기 반응식 4에 따라 폰티카에폭사이드를 제조하였다. Ponticaepoxide was prepared according to Scheme 4 below.

[반응식 4][Reaction Scheme 4]

Figure 112010054670377-pat00059
Figure 112010054670377-pat00059

실시예Example 4-1:( 4-1 :( EE )-) - 데카Deca -2-엔-4,6,8-트린-1-올의 제조Preparation of 2-ene-4,6,8-trin-1-ol

[화학식 25] (25)

Figure 112010054670377-pat00060
Figure 112010054670377-pat00060

합성한 화학식 20의 화합물 트라이엔주석화합물(트라이부틸(헵타-1,3,5-트리닐)스탄난) 1당량을 건조 플라스크에 넣은 다음에 10 mol% 화학식 22의 팔라듐촉매(PdCl2(PPh3)2), 화학식 23의 CuI 0.3 당량을 넣었다. 반응 유기용매로서 테트라하이드로퓨란(THF)를 넣었다. 테트라히드로퓨란(THF)에 묽힌 화학식 21의 화합물인 (E)-3-(아이오도알릴옥시)트라이메틸실란 1 당량을 넣은 후 실온에서 2시간 동안 반응시켰다.1 equivalent of the synthesized triene tin compound (tributyl (hepta-1,3,5-triyl) stannan) of the compound of formula 20 was added to a dry flask, and then 10 mol% of the palladium catalyst of formula 22 (PdCl 2 (PPh 3 ) 2 ), 0.3 equivalent of CuI of the formula (23) was added. Tetrahydrofuran (THF) was added as a reaction organic solvent. 1 equivalent of (E) -3- (iodoallyloxy) trimethylsilane, a compound of Formula 21 diluted in tetrahydrofuran (THF), was added and allowed to react at room temperature for 2 hours.

반응용매를 증발시킨 후 감압 여과하였다. 이렇게 얻은 생성물을 반응용기에 넣은 후 반응용매로 메탄올을 넣고 그리고 0℃에서 화학식 24의 탄산칼륨(K2CO3) 5 당량을 가하였다. 그 다음 물을 넣어 반응을 종결시킨 후, 에테르(Et2O)로 추출하고 황산나트륨(Na2SO4)으로 건조시켰다. 그리고 컬럼 크로마토그래피로 정제하였다.The reaction solvent was evaporated and filtered under reduced pressure. The product thus obtained was placed in a reaction vessel, methanol was added as a reaction solvent, and 5 equivalents of potassium carbonate (K 2 CO 3 ) of Chemical Formula 24 was added at 0 ° C. Then, the reaction was terminated by adding water, followed by extraction with ether (Et 2 O) and drying with sodium sulfate (Na 2 SO 4 ). And purified by column chromatography.

수율: 62% Yield: 62%

TLC, Rf 0.37 (2:1 Hexanes/EtOAc)TLC, R f 0.37 (2: 1 Hexanes / EtOAc)

IR(film) 3053, 2985, 2357, 2305, 2223 cm-1 IR (film) 3053, 2985, 2357, 2305, 2223 cm -1

1H NMR (300MHz, CDCl3): δ 1.61 (s, 1H), 1.98 (s, 3H), 4.25 (s, 2H), 5.80 (d, J = 15.9 Hz, 1H), 6.46 (dt, J = 4.5, 15.9Hz, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.61 (s, 1H), 1.98 (s, 3H), 4.25 (s, 2H), 5.80 (d, J = 15.9 Hz, 1H), 6.46 (dt, J = 4.5, 15.9 Hz, 1H)

13C NMR (75MHz, CDCl3): δ 4.8, 59.0, 62.8, 64.9, 67.2, 73.6, 75.2, 78.3, 108.4, 146.9 13 C NMR (75 MHz, CDCl 3 ): δ 4.8, 59.0, 62.8, 64.9, 67.2, 73.6, 75.2, 78.3, 108.4, 146.9

MS m/z (%) 144 (M+)
MS m / z (%) 144 (M +)

실시예Example 4-2: (E)- 4-2: (E)- 데카Deca -2-엔-4,6,8-2-en-4,6,8- 트리날의Trinal 제조 Produce

[화학식 27](27)

Figure 112010054670377-pat00061
Figure 112010054670377-pat00061

화학식 21의 화합물인 (E)-데카-2-엔-4,6,8-트라인-1-올 1 당량과 활성화된 화학식 26의 이산화망간(Activated MnO2) 15 당량을 반응용기에 넣은 후 반응용매로 디클로로메탄을 넣었다. 실온에서 3시간 동안 반응 시킨 후 화합물을 여과한 다음 감압 증류하였다. 실리카젤 크로마토그래피를 통하여 최종적으로 정제하여 화학식 26의 알데히드 화합물을 얻었다.1 equivalent of ( E ) -deca-2-ene-4,6,8-tri-1-ol and 15 equivalents of activated MnO 2 of formula 26 were added to a reaction vessel, followed by reaction. Dichloromethane was added as a solvent. After reacting for 3 hours at room temperature, the compound was filtered and then distilled under reduced pressure. Finally purified by silica gel chromatography to obtain the aldehyde compound of formula 26.

수율:97%Yield: 97%

TLC, Rf 0.43 (5:1 Hexanes/EtOAc) TLC, R f 0.43 (5: 1 Hexanes / EtOAc)

IR(film): 3062, 3053, 3027, 2916, 2851, 2825, 2220, 2168, 1734, 1718 cm-1 IR (film): 3062, 3053, 3027, 2916, 2851, 2825, 2220, 2168, 1734, 1718 cm -1

1H NMR (300MHz, CDCl3): δ 2.04 (s, 3H), 6.59 (m, 2H), 9.58 (m, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.04 (s, 3H), 6.59 (m, 2H), 9.58 (m, 1H)

13C NMR (75MHz, CDCl3): δ 4.8, 57.7, 64.6, 70.8, 73.8, 82.4, 88.3, 130.3, 142.2, 192.6 13 C NMR (75 MHz, CDCl 3 ): δ 4.8, 57.7, 64.6, 70.8, 73.8, 82.4, 88.3, 130.3, 142.2, 192.6

MS m/z (%) 142 (M+)
MS m / z (%) 142 (M +)

실시예Example 4-3: (+)-( 4-3: (+)-( EE )-3-) -3- 클로로트리데카Chlorotrideca -1,5--1,5- 다이엔Diene -7,9,11-트린-4-올의 제조Preparation of -7,9,11-Trin-4-ol

[화학식 28](28)

Figure 112010054670377-pat00062
Figure 112010054670377-pat00062

위 화합물은 화학식 13-1의 (S,S)-카이랄 보란을 사용한 것을 제외하고는 실시예 2-7과 통일한 방법을 통해 얻었다.The above compound was obtained by the same method as Example 2-7 except for using (S, S) -chiral borane of Chemical Formula 13-1.

수율:97%Yield: 97%

TLC, Rf 0.43 (5:1 Hexanes/EtOAc) TLC, R f 0.43 (5: 1 Hexanes / EtOAc)

IR(film): 3062, 3053, 3027, 2916, 2851, 2825, 2220, 2168, 1734, 1718 cm-1 IR (film): 3062, 3053, 3027, 2916, 2851, 2825, 2220, 2168, 1734, 1718 cm -1

1H NMR (300MHz, CDCl3): δ 2.04 (s, 3H), 6.59 (m, 2H), 9.58 (m, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 2.04 (s, 3H), 6.59 (m, 2H), 9.58 (m, 1H)

13C NMR (75MHz, CDCl3): δ 4.8, 57.7, 64.6, 70.8, 73.8, 82.4, 88.3, 130.3, 142.2, 192.6 13 C NMR (75 MHz, CDCl 3 ): δ 4.8, 57.7, 64.6, 70.8, 73.8, 82.4, 88.3, 130.3, 142.2, 192.6

MS m/z (%) 142 (M+)
MS m / z (%) 142 (M +)

실시예Example 4-4: (-)-(E)-2-(노나-1-엔-3,5,7- 4-4: (-)-(E) -2- (nona-1-ene-3,5,7- 트리닐Trinyl )-3-) -3- 비닐옥시란의Vinyloxirane 제조 Produce

[화학식 29] [Formula 29]

Figure 112010054670377-pat00063
Figure 112010054670377-pat00063

위 화합물은 실시예 3-1과 동일한 방법을 통해 얻었다.The above compound was obtained by the same method as in Example 3-1.

수율: 75%Yield: 75%

(α]D 20 -48.29° (c 0.14, CHCl3) (α) D 20 -48.29 ° (c 0.14, CHCl 3 )

TLC, Rf 0.57 (5:1 Hexanes/EtOAc)TLC, R f 0.57 (5: 1 Hexanes / EtOAc)

IR(film): 2978, 2911, 2355, 2343, 2221 cm-1 IR (film): 2978, 2911, 2355, 2343, 2221 cm -1

1H NMR (300MHz, CDCl3): δ 1.99 (s, 3H), 3.18-3.23 (m, 2H), 5.33 (dd, J = 2.1, 9.3 Hz, 1H), 5.49 (dd, J = 2.1, 15.9 Hz, 1H), 5.59 (ddd, J= 6.6, 9.3, 15.9 Hz, 1H), 5.87 (d, J = 15.9 Hz, 1H), 6.12 (dd, J = 6.6, 15.9 Hz, 1H) 1 H NMR (300 MHz, CDCl 3 ): δ 1.99 (s, 3H), 3.18-3.23 (m, 2H), 5.33 (dd, J = 2.1, 9.3 Hz, 1H), 5.49 (dd, J = 2.1, 15.9 Hz, 1H), 5.59 (ddd, J = 6.6, 9.3, 15.9 Hz, 1H), 5.87 (d, J = 15.9 Hz, 1H), 6.12 (dd, J = 6.6, 15.9 Hz, 1H)

13C NMR (75MHz, CDCl3): δ 4.8, 29.8, 58.8, 59.1, 61.3, 64.9, 68.1, 72.8, 78.8, 111.7, 120.3, 134.2, 144.0 13 C NMR (75 MHz, CDCl 3 ): δ 4.8, 29.8, 58.8, 59.1, 61.3, 64.9, 68.1, 72.8, 78.8, 111.7, 120.3, 134.2, 144.0

MS m/z (%) 182 (M+)MS m / z (%) 182 (M +)

Claims (30)

(S1) 화학식 8-1의 염소 함유 설퍼 일리드(sulfur ylide)와 화학식 13의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 8-1]
Figure 112010054670377-pat00064

[화학식 13]
Figure 112010054670377-pat00065

(식중, Tol은 4-메틸페닐임)
(S2) 상기 알릴전이시약과 화학식 14의 알데히드를 반응시켜 화학식 15의 anti-비닐클로로하이드린을 얻는 단계; 및
[화학식 14]
R-CHO
[화학식 15]
Figure 112010054670377-pat00066

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
(S3) 상기 anti-비닐클로로하이드린을 염기와 반응시켜 화학식 17의 트랜스-비닐옥시란 유도체를 생성하는 단계
[화학식 17]
Figure 112010054670377-pat00067

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
를 포함하는 트랜스-비닐옥시란의 제조방법.
(S1) reacting a chlorine-containing sulfur ylide of Formula 8-1 with a chiral borane of Formula 13 to obtain an allyl transfer reagent;
[Formula 8-1]
Figure 112010054670377-pat00064

[Chemical Formula 13]
Figure 112010054670377-pat00065

Wherein Tol is 4-methylphenyl
(S2) reacting the allyl transition reagent with an aldehyde of Formula 14 to obtain an anti-vinylchlorohydrin of Formula 15; And
[Chemical Formula 14]
R-CHO
[Chemical Formula 15]
Figure 112010054670377-pat00066

(Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
(S3) reacting the anti-vinylchlorohydrin with a base to produce a trans-vinyloxirane derivative of Formula 17
[Chemical Formula 17]
Figure 112010054670377-pat00067

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
Method for producing a trans-vinyl oxirane containing.
(S1) 화학식 8-1의 염소 함유 설퍼 일리드와 화학식 13-1의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 8-1]
Figure 112010054670377-pat00068

[화학식 13-1]
Figure 112010054670377-pat00069

(식중, Tol은 4-메틸페닐임)
(S2) 상기 알릴전이시약과 화학식 14의 알데히드를 반응시켜 화학식 15-1의 anti-비닐클로로하이드린을 얻는 단계; 및
[화학식 14]
R-CHO
[화학식 15-1]
Figure 112010054670377-pat00070

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
(S3) 상기 anti-비닐클로로하이드린을 염기와 반응시켜 화학식 17-1의 트랜스-비닐옥시란 유도체를 생성하는 단계
[화학식 17-1]
Figure 112010054670377-pat00071

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
를 포함하는 트랜스-비닐옥시란의 제조방법.
(S1) reacting a chlorine-containing sulfide of Formula 8-1 with a chiral borane of Formula 13-1 to obtain an allyl transfer reagent;
[Formula 8-1]
Figure 112010054670377-pat00068

[Formula 13-1]
Figure 112010054670377-pat00069

Wherein Tol is 4-methylphenyl
(S2) reacting the allyl transfer reagent with an aldehyde of Formula 14 to obtain an anti-vinylchlorohydrin of Formula 15-1; And
[Chemical Formula 14]
R-CHO
[Formula 15-1]
Figure 112010054670377-pat00070

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
(S3) reacting the anti-vinylchlorohydrin with a base to produce a trans-vinyloxirane derivative of Formula 17-1
[Formula 17-1]
Figure 112010054670377-pat00071

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
Method for producing a trans-vinyl oxirane containing.
제1항 또는 제2항에 있어서,
R이 페닐, 벤질, 시클로헥실, 페닐에테닐, 페닐에티닐 또는 페닐에틸인 것을 특징으로 하는 트랜스-비닐옥시란의 제조방법.
The method according to claim 1 or 2,
R is phenyl, benzyl, cyclohexyl, phenylethenyl, phenylethynyl or phenylethyl.
제1항 또는 제2항에 있어서,
(S3) 단계에서 사용되는 염기가 DBU(1,8-디아자비시클로[5,4,0]운데스-7-엔)인 것을 특징으로 하는 트랜스-비닐옥시란의 제조방법.
The method according to claim 1 or 2,
The base used in step (S3) is DBU (1,8- diazabicyclo [5,4,0] undes-7-ene) The method for producing trans-vinyl oxirane, characterized in that.
제1항 또는 제2항에 있어서,
각 단계의 반응은 용매 중에서 실시하며, (S1) 및 (S2) 단계의 용매는 테트라하이드로퓨란이고, (S3) 단계의 용매는 디클로로메탄인 것을 특징으로 하는 트랜스-비닐옥시란의 제조방법.
The method according to claim 1 or 2,
The reaction of each step is carried out in a solvent, the solvent of step (S1) and (S2) is tetrahydrofuran, and the solvent of step (S3) is dichloromethane.
제1항 또는 제2항에 있어서, (S1) 단계 이전에,
(a) 화학식 8의 염소 함유 설포늄 이온을 제공하는 단계; 및
[화학식 8]
Figure 112010054670377-pat00072

(b) 상기 염소 함유 설포늄 이온을 메틸리튬과 반응시켜 화학식 8-1의 염소 함유 설퍼 일리드를 제공하는 단계
[화학식 8-1]
Figure 112010054670377-pat00073

를 더 포함하는 것을 특징으로 하는 트랜스-비닐옥시란의 제조방법.
The method according to claim 1 or 2, before step (S1),
(a) providing a chlorine containing sulfonium ion of Formula 8; And
[Chemical Formula 8]
Figure 112010054670377-pat00072

(b) reacting the chlorine-containing sulfonium ions with methyllithium to provide a chlorine-containing sulfide of formula 8-1
[Formula 8-1]
Figure 112010054670377-pat00073

Method for producing a trans-vinyl oxirane characterized in that it further comprises.
제6항에 있어서, 상기 (a) 단계는,
(a1) 화학식 1의 화합물, 부틸리튬 및 화학식 4의 화합물을 반응시켜 화학식 5의 화합물을 얻는 단계; 및
[화학식 1]
Figure 112010054670377-pat00074

[화학식 4]
Figure 112010054670377-pat00075

(식중, Me는 메틸임)
[화학식 5]
Figure 112010054670377-pat00076

(식중, Ts는
Figure 112010054670377-pat00077
이고, Me는 메틸임)
(a2) 상기 화학식 5의 화합물을 테트라하이드로사이오펜과 반응시켜 화학식 8의 염소 함유 설포늄 이온을 제공하는 단계
[화학식 8]
Figure 112010054670377-pat00078

(식중, Ts는
Figure 112010054670377-pat00079
이고, Me는 메틸임)
를 더 포함하는 것을 특징으로 하는 트랜스-비닐옥시란의 제조방법.
According to claim 6, wherein step (a),
(a1) reacting a compound of Formula 1, butyllithium and a compound of Formula 4 to obtain a compound of Formula 5; And
[Formula 1]
Figure 112010054670377-pat00074

[Chemical Formula 4]
Figure 112010054670377-pat00075

Wherein Me is methyl
[Chemical Formula 5]
Figure 112010054670377-pat00076

(Ts is
Figure 112010054670377-pat00077
Me is methyl)
(a2) reacting the compound of Formula 5 with tetrahydrothiophene to provide a chlorine-containing sulfonium ion of Formula 8
[Chemical Formula 8]
Figure 112010054670377-pat00078

(Ts is
Figure 112010054670377-pat00079
Me is methyl)
Method for producing a trans-vinyl oxirane characterized in that it further comprises.
(S1) 화학식 9-1의 염소 함유 설퍼 일리드와 화학식 13의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 9-1]
Figure 112010054670377-pat00080

[화학식 13]
Figure 112010054670377-pat00081

(식중, Tol은 4-메틸페닐임)
(S2) 상기 알릴전이시약과 화학식 14의 알데히드를 반응시켜 화학식 16의 syn-비닐클로로하이드린을 얻는 단계;
[화학식 14]
R-CHO
[화학식 16]
Figure 112010054670377-pat00082

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
(S3) 상기 syn-비닐클로로하이드린을 염기와 반응시켜 화학식 18의 시스-비닐옥시란 유도체를 생성하는 단계
[화학식 18]
Figure 112010054670377-pat00083

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
를 포함하는 시스-비닐옥시란의 제조방법.
(S1) reacting a chlorine-containing sulfide of Formula 9-1 with a chiral borane of Formula 13 to obtain an allyl transfer reagent;
[Formula 9-1]
Figure 112010054670377-pat00080

[Chemical Formula 13]
Figure 112010054670377-pat00081

Wherein Tol is 4-methylphenyl
(S2) reacting the allyl transfer reagent with an aldehyde of Formula 14 to obtain syn-vinylchlorohydrin of Formula 16;
[Chemical Formula 14]
R-CHO
[Chemical Formula 16]
Figure 112010054670377-pat00082

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
(S3) reacting the syn-vinylchlorohydrin with a base to produce a cis-vinyloxirane derivative of Formula 18
[Chemical Formula 18]
Figure 112010054670377-pat00083

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
Method for producing cis-vinyl oxirane comprising a.
(S1) 화학식 9-1의 염소 함유 설퍼 일리드와 화학식 13-1의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 9-1]
Figure 112010054670377-pat00084

[화학식 13-1]
Figure 112010054670377-pat00085

(식중, Tol은 4-메틸페닐임)
(S2) 상기 알릴전이시약과 화학식 14의 알데히드를 반응시켜 화학식 16-1의 syn-비닐클로로하이드린을 얻는 단계;
[화학식 14]
R-CHO
[화학식 16-1]
Figure 112010054670377-pat00086

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
(S3) 상기 syn-비닐클로로하이드린을 염기와 반응시켜 화학식 18-1의 시스-비닐옥시란 유도체를 생성하는 단계
[화학식 18-1]
Figure 112010054670377-pat00087

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
를 포함하는 시스-비닐옥시란의 제조방법.
(S1) reacting a chlorine-containing sulfide of Formula 9-1 with a chiral borane of Formula 13-1 to obtain an allyl transfer reagent;
[Formula 9-1]
Figure 112010054670377-pat00084

[Formula 13-1]
Figure 112010054670377-pat00085

Wherein Tol is 4-methylphenyl
(S2) reacting the allyl transition reagent with an aldehyde of Formula 14 to obtain syn-vinylchlorohydrin of Formula 16-1;
[Chemical Formula 14]
R-CHO
[Formula 16-1]
Figure 112010054670377-pat00086

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
(S3) reacting the syn-vinylchlorohydrin with a base to generate a cis-vinyloxirane derivative of Formula 18-1
[Formula 18-1]
Figure 112010054670377-pat00087

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
Method for producing cis-vinyl oxirane comprising a.
제8항 또는 제9항에 있어서,
R이 페닐, 벤질, 시클로헥실, 페닐에테닐, 페닐에티닐 또는 페닐에틸인 것을 특징으로 하는 시스-비닐옥시란의 제조방법.
10. The method according to claim 8 or 9,
R is phenyl, benzyl, cyclohexyl, phenylethenyl, phenylethynyl or phenylethyl.
제8항 또는 제9항에 있어서,
(S3) 단계에서 사용되는 염기가 1,8-디아자비시클로[5,4,0]운데스-7-엔(DBU)인 것을 특징으로 하는 시스-비닐옥시란의 제조방법.
10. The method according to claim 8 or 9,
A process for producing cis-vinyl oxirane, characterized in that the base used in step (S3) is 1,8-diazabicyclo [5,4,0] undes-7-ene (DBU).
제8항 또는 제9항에 있어서,
각 단계의 반응은 용매 중에서 실시하며, (S1) 및 (S2) 단계의 용매는 테트라하이드로퓨란이고, (S3) 단계의 용매는 디클로로메탄인 것을 특징으로 하는 시스-비닐옥시란의 제조방법.
10. The method according to claim 8 or 9,
The reaction of each step is carried out in a solvent, the solvent of step (S1) and (S2) is tetrahydrofuran, and the solvent of step (S3) is dichloromethane.
제8항 또는 제9항에 있어서, (S1) 단계 이전에,
(a) 화학식 9의 염소 함유 설포늄 이온을 제공하는 단계; 및
[화학식 9]
Figure 112010054670377-pat00088

(식중, Ts는
Figure 112010054670377-pat00089
이고, Me는 메틸임)
(b) 상기 염소 함유 설포늄 이온을 메틸리튬과 반응시켜 화학식 9-1의 염소 함유 설퍼 일리드를 제공하는 단계
[화학식 9-1]
Figure 112010054670377-pat00090

를 더 포함하는 것을 특징으로 하는 시스-비닐옥시란의 제조방법.
The method according to claim 8 or 9, before step (S1),
(a) providing a chlorine containing sulfonium ion of Formula 9; And
[Chemical Formula 9]
Figure 112010054670377-pat00088

(Ts is
Figure 112010054670377-pat00089
Me is methyl)
(b) reacting the chlorine-containing sulfonium ions with methyllithium to provide a chlorine-containing sulfide of formula 9-1
[Formula 9-1]
Figure 112010054670377-pat00090

Method for producing cis-vinyl oxirane further comprising.
제13항에 있어서, 상기 (a) 단계는,
(a1) 화학식 2의 화합물, 부틸리튬 및 화학식 4의 화합물을 반응시켜 화학식 6의 화합물을 얻는 단계; 및
[화학식 2]
Figure 112010054670377-pat00091

[화학식 4]
Figure 112010054670377-pat00092

(식중, Me는 메틸임)
[화학식 6]
Figure 112010054670377-pat00093

(식중, Ts는
Figure 112010054670377-pat00094
이고, Me는 메틸임)
(a2) 상기 화학식 6의 화합물을 테트라하이드로사이오펜과 반응시켜 화학식 9의 염소 함유 설포늄 이온을 제공하는 단계
[화학식 9]
Figure 112010054670377-pat00095

(식중, Ts는
Figure 112010054670377-pat00096
이고, Me는 메틸임)
를 더 포함하는 것을 특징으로 하는 시스-비닐옥시란의 제조방법.
The method of claim 13, wherein step (a) comprises:
(a1) reacting a compound of Formula 2, butyllithium and a compound of Formula 4 to obtain a compound of Formula 6; And
(2)
Figure 112010054670377-pat00091

[Chemical Formula 4]
Figure 112010054670377-pat00092

Wherein Me is methyl
[Chemical Formula 6]
Figure 112010054670377-pat00093

(Ts is
Figure 112010054670377-pat00094
Me is methyl)
(a2) reacting the compound of Formula 6 with tetrahydrothiophene to provide a chlorine-containing sulfonium ion of Formula 9
[Chemical Formula 9]
Figure 112010054670377-pat00095

(Ts is
Figure 112010054670377-pat00096
Me is methyl)
Method for producing cis-vinyl oxirane further comprising.
(i) 화학식 8-1 또는 화학식 9-1 중에서 선택되는 염소 함유 설퍼 일리드; 및
[화학식 8-1]
Figure 112010054670377-pat00097

[화학식 9-1]
Figure 112010054670377-pat00098

(ii) 화학식 13 또는 화학식 13-1 중에서 선택되는 카이랄 보란
[화학식 13]
Figure 112010054670377-pat00099

[화학식 13-1]
Figure 112010054670377-pat00100

(식중, Tol은 4-메틸페닐임)
을 반응시켜 얻은 알릴전이시약.
(i) chlorine-containing sulfides selected from formulas 8-1 or 9-1; And
[Formula 8-1]
Figure 112010054670377-pat00097

[Formula 9-1]
Figure 112010054670377-pat00098

(ii) a chiral borane selected from formula 13 or formula 13-1
[Chemical Formula 13]
Figure 112010054670377-pat00099

[Formula 13-1]
Figure 112010054670377-pat00100

Wherein Tol is 4-methylphenyl
Allyl transfer reagent obtained by reacting.
이하의 구조식을 갖는 폰티카에폭사이드의 제조방법으로서,
Figure 112010054670377-pat00101

(식중, Me는 메틸임)
(S1) 화학식 8의 설포늄 이온을 메틸리튬과 반응시켜 화학식 8-1의 염소 함유 설퍼일리드를 얻는 단계;
[화학식 8]
Figure 112010054670377-pat00102

(식중, Ts는
Figure 112010054670377-pat00103
이고, Me는 메틸임)
[화학식 8-1]
Figure 112010054670377-pat00104

(S2) 상기 화학식 8-1의 염소 함유 설퍼 일리드와 화학식 13-1의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 13-1]
Figure 112010054670377-pat00105

(식중, Tol은 4-메틸페닐임)
(S3) 상기 알릴전이시약을 화학식 27의 알데히드와 반응시켜 화학식 28의 비닐클로로하이드린을 생성하는 단계; 및
[화학식 27]
Figure 112010054670377-pat00106

[화학식 28]
Figure 112010054670377-pat00107

(S4) 상기 비닐클로로하이드린을 DBU와 반응시키는 단계
를 포함하는 폰티카에폭사이드의 제조방법.
As a method for producing pontica epoxide having the following structural formula,
Figure 112010054670377-pat00101

Wherein Me is methyl
(S1) reacting sulfonium ions of formula 8 with methyllithium to obtain chlorine-containing sulfides of formula 8-1;
[Chemical Formula 8]
Figure 112010054670377-pat00102

(Ts is
Figure 112010054670377-pat00103
Me is methyl)
[Formula 8-1]
Figure 112010054670377-pat00104

(S2) reacting the chlorine-containing sulfide of Formula 8-1 with the chiral borane of Formula 13-1 to obtain an allyl transfer reagent;
[Formula 13-1]
Figure 112010054670377-pat00105

Wherein Tol is 4-methylphenyl
(S3) reacting the allyl transfer reagent with an aldehyde of Formula 27 to generate vinylchlorohydrin of Formula 28; And
[Formula 27]
Figure 112010054670377-pat00106

[Formula 28]
Figure 112010054670377-pat00107

(S4) reacting the vinylchlorohydrin with DBU
Method for producing a ponta epoxide comprising a.
하기 화학식 8의 화합물.
[화학식 8]
Figure 112010054670377-pat00108

(식중, Ts는
Figure 112010054670377-pat00109
이고, Me는 메틸임)
A compound of formula
[Chemical Formula 8]
Figure 112010054670377-pat00108

(Ts is
Figure 112010054670377-pat00109
Me is methyl)
하기 화학식 9의 화합물.
[화학식 9]
Figure 112010054670377-pat00110

(식중, Ts는
Figure 112010054670377-pat00111
이고, Me는 메틸임)
A compound of formula (9)
[Chemical Formula 9]
Figure 112010054670377-pat00110

(Ts is
Figure 112010054670377-pat00111
Me is methyl)
(S1) 화학식 8-1의 염소 함유 설퍼 일리드와 화학식 13의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 8-1]
Figure 112010054670377-pat00112

[화학식 13]
Figure 112010054670377-pat00113

(식중, Tol은 4-메틸페닐임)
(S2) 상기 알릴전이시약과 화학식 14의 알데히드를 반응시키는 단계
[화학식 14]
R-CHO
를 포함하는 화학식 15의 anti-비닐클로로하이드린의 제조 방법.
[화학식 15]
Figure 112010054670377-pat00114

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
(S1) reacting a chlorine-containing sulfide of Formula 8-1 with a chiral borane of Formula 13 to obtain an allyl transfer reagent;
[Formula 8-1]
Figure 112010054670377-pat00112

[Chemical Formula 13]
Figure 112010054670377-pat00113

Wherein Tol is 4-methylphenyl
(S2) reacting the allyl transition reagent with an aldehyde of Formula 14
[Chemical Formula 14]
R-CHO
Method for producing an anti-vinylchlorohydrin of the formula (15) comprising a.
[Chemical Formula 15]
Figure 112010054670377-pat00114

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
(S1) 화학식 8-1의 염소 함유 설퍼 일리드와 화학식 13-1의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 8-1]
Figure 112010054670377-pat00115

[화학식 13-1]
Figure 112010054670377-pat00116

(식중, Tol은 4-메틸페닐임)
(S2) 상기 알릴전이시약과 화학식 14의 알데히드를 반응시키는 단계
[화학식 14]
R-CHO
를 포함하는 화학식 15-1의 anti-비닐클로로하이드린의 제조 방법
[화학식 15-1]
Figure 112010054670377-pat00117

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
(S1) reacting a chlorine-containing sulfide of Formula 8-1 with a chiral borane of Formula 13-1 to obtain an allyl transfer reagent;
[Formula 8-1]
Figure 112010054670377-pat00115

[Formula 13-1]
Figure 112010054670377-pat00116

Wherein Tol is 4-methylphenyl
(S2) reacting the allyl transition reagent with an aldehyde of Formula 14
[Chemical Formula 14]
R-CHO
Method for producing an anti-vinylchlorohydrin of formula 15-1 containing
[Formula 15-1]
Figure 112010054670377-pat00117

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
제19항 또는 제20항에 있어서,
R이 페닐, 벤질, 시클로헥실, 페닐에테닐, 페닐에티닐 또는 페닐에틸인 것을 특징으로 하는 anti-비닐클로로하이드린의 제조 방법.
21. The method according to claim 19 or 20,
R is phenyl, benzyl, cyclohexyl, phenylethenyl, phenylethynyl or phenylethyl. A process for producing anti-vinylchlorohydrin.
제19항 또는 제20항에 있어서,
각 단계의 반응은 용매 중에서 실시하며, (S1) 및 (S2) 단계의 용매는 테트라하이드로퓨란인 것을 특징으로 하는 anti-비닐클로로하이드린의 제조 방법.
21. The method according to claim 19 or 20,
The reaction of each step is carried out in a solvent, the solvent of step (S1) and (S2) is a method for producing anti-vinylchlorohydrin, characterized in that tetrahydrofuran.
제19항 또는 제20항에 있어서, (S1) 단계 이전에,
(a) 화학식 8의 염소 함유 설포늄 이온을 제공하는 단계; 및
[화학식 8]
Figure 112010054670377-pat00118

(식중, Ts는
Figure 112010054670377-pat00119
이고, Me는 메틸임)
(b) 상기 염소 함유 설포늄 이온을 메틸리튬과 반응시켜 화학식 8-1의 염소 함유 설퍼 일리드를 제공하는 단계
[화학식 8-1]
Figure 112010054670377-pat00120

를 더 포함하는 것을 특징으로 하는 anti-비닐클로로하이드린의 제조 방법.
The method according to claim 19 or 20, before step (S1),
(a) providing a chlorine containing sulfonium ion of Formula 8; And
[Chemical Formula 8]
Figure 112010054670377-pat00118

(Ts is
Figure 112010054670377-pat00119
Me is methyl)
(b) reacting the chlorine-containing sulfonium ions with methyllithium to provide a chlorine-containing sulfide of formula 8-1
[Formula 8-1]
Figure 112010054670377-pat00120

Method for producing an anti-vinyl chlorohydrin further comprising.
제23항에 있어서, 상기 (a) 단계는,
(a1) 화학식 1의 화합물, 부틸리튬 및 화학식 4의 화합물을 반응시켜 화학식 5의 화합물을 얻는 단계; 및
[화학식 1]
Figure 112010054670377-pat00121

[화학식 4]
Figure 112010054670377-pat00122

(식중, Me는 메틸임)
[화학식 5]
Figure 112010054670377-pat00123

(식중, Ts는
Figure 112010054670377-pat00124
이고, Me는 메틸임)
(a2) 상기 화학식 5의 화합물을 테트라하이드로사이오펜과 반응시켜 화학식 8의 염소 함유 설포늄 이온을 제공하는 단계
[화학식 8]
Figure 112010054670377-pat00125

(식중, Ts는
Figure 112010054670377-pat00126
이고, Me는 메틸임)
를 더 포함하는 것을 특징으로 하는 anti-비닐클로로하이드린의 제조 방법.
The method of claim 23, wherein step (a) comprises:
(a1) reacting a compound of Formula 1, butyllithium and a compound of Formula 4 to obtain a compound of Formula 5; And
[Formula 1]
Figure 112010054670377-pat00121

[Chemical Formula 4]
Figure 112010054670377-pat00122

Wherein Me is methyl
[Chemical Formula 5]
Figure 112010054670377-pat00123

(Ts is
Figure 112010054670377-pat00124
Me is methyl)
(a2) reacting the compound of Formula 5 with tetrahydrothiophene to provide a chlorine-containing sulfonium ion of Formula 8
[Chemical Formula 8]
Figure 112010054670377-pat00125

(Ts is
Figure 112010054670377-pat00126
Me is methyl)
Method for producing an anti-vinyl chlorohydrin further comprising.
(S1) 화학식 9-1의 염소 함유 설퍼 일리드와 화학식 13의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 9-1]
Figure 112010054670377-pat00127

[화학식 13]
Figure 112010054670377-pat00128

(식중, Tol은 4-메틸페닐임)
(S2) 상기 알릴전이시약과 화학식 14의 알데히드를 반응시키는 단계;
[화학식 14]
R-CHO
를 포함하는 화학식 16의 syn-비닐클로로하이드린의 제조 방법.
[화학식 16]
Figure 112010054670377-pat00129

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
(S1) reacting a chlorine-containing sulfide of Formula 9-1 with a chiral borane of Formula 13 to obtain an allyl transfer reagent;
[Formula 9-1]
Figure 112010054670377-pat00127

[Chemical Formula 13]
Figure 112010054670377-pat00128

Wherein Tol is 4-methylphenyl
(S2) reacting the allyl transfer reagent with an aldehyde of Formula 14;
[Chemical Formula 14]
R-CHO
Method of producing a syn-vinylchlorohydrin of the formula (16) comprising a.
[Chemical Formula 16]
Figure 112010054670377-pat00129

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
(S1) 화학식 9-1의 염소 함유 설퍼 일리드와 화학식 13-1의 카이랄 보란을 반응시켜 알릴전이시약을 얻는 단계;
[화학식 9-1]
Figure 112010054670377-pat00130

[화학식 13-1]
Figure 112010054670377-pat00131

(식중, Tol은 4-메틸페닐임)
(S2) 상기 알릴전이시약과 화학식 14의 알데히드를 반응시키는 단계
[화학식 14]
R-CHO
를 포함하는 화학식 16-1의 syn-비닐클로로하이드린의 제조방법.
[화학식 16-1]
Figure 112010054670377-pat00132

(식중, R은 알킬, 알케닐기, 알키닐기, 시클로알킬, 아릴, 아랄킬기, 아랄케닐기, 또는 아랄키닐기임)
(S1) reacting a chlorine-containing sulfide of Formula 9-1 with a chiral borane of Formula 13-1 to obtain an allyl transfer reagent;
[Formula 9-1]
Figure 112010054670377-pat00130

[Formula 13-1]
Figure 112010054670377-pat00131

Wherein Tol is 4-methylphenyl
(S2) reacting the allyl transition reagent with an aldehyde of Formula 14
[Chemical Formula 14]
R-CHO
Method of producing syn-vinylchlorohydrin of the formula (16-1) comprising a.
[Formula 16-1]
Figure 112010054670377-pat00132

Wherein R is an alkyl, alkenyl group, alkynyl group, cycloalkyl, aryl, aralkyl group, arkenyl group, or aralkylyl group)
제25항 또는 제26항에 있어서,
R이 페닐, 벤질, 시클로헥실, 페닐에테닐, 페닐에티닐 또는 페닐에틸인 것을 특징으로 하는 syn-비닐클로로하이드린의 제조 방법.
27. The method of claim 25 or 26,
R is phenyl, benzyl, cyclohexyl, phenylethenyl, phenylethynyl or phenylethyl. The process for producing syn-vinylchlorohydrin.
제25항 또는 제26항에 있어서,
각 단계의 반응은 용매 중에서 실시하며, (S1) 및 (S2) 단계의 용매는 테트라하이드로퓨란인 것을 특징으로 하는 syn-비닐클로로하이드린의 제조 방법.
27. The method of claim 25 or 26,
The reaction of each step is carried out in a solvent, the solvent of step (S1) and (S2) is a method for producing syn-vinylchlorohydrin, characterized in that tetrahydrofuran.
제25항 또는 제26항에 있어서, (S1) 단계 이전에,
(a) 화학식 9의 염소 함유 설포늄 이온을 제공하는 단계; 및
[화학식 9]
Figure 112010054670377-pat00133

(식중, Ts는
Figure 112010054670377-pat00134
이고, Me는 메틸임)
(b) 상기 염소 함유 설포늄 이온을 메틸리튬과 반응시켜 화학식 9-1의 염소 함유 설퍼 일리드를 제공하는 단계
[화학식 9-1]
Figure 112010054670377-pat00135

를 더 포함하는 것을 특징으로 하는 syn-비닐클로로하이드린의 제조 방법.
The method of claim 25 or 26, wherein, prior to step (S1),
(a) providing a chlorine containing sulfonium ion of Formula 9; And
[Chemical Formula 9]
Figure 112010054670377-pat00133

(Ts is
Figure 112010054670377-pat00134
Me is methyl)
(b) reacting the chlorine-containing sulfonium ions with methyllithium to provide a chlorine-containing sulfide of formula 9-1
[Formula 9-1]
Figure 112010054670377-pat00135

Method of producing a syn-vinyl chlorohydrin further comprises.
제29항에 있어서, 상기 (a) 단계는,
(a1) 화학식 2의 화합물, 부틸리튬 및 화학식 4의 화합물을 반응시켜 화학식 6의 화합물을 얻는 단계; 및
[화학식 2]
Figure 112010054670377-pat00136

[화학식 4]
Figure 112010054670377-pat00137

(식중, Me는 메틸임)
[화학식 6]
Figure 112010054670377-pat00138

(식중, Ts는
Figure 112010054670377-pat00139
이고, Me는 메틸임)
(a2) 상기 화학식 6의 화합물을 테트라하이드로사이오펜과 반응시켜 화학식 9의 염소 함유 설포늄 이온을 제공하는 단계
[화학식 9]
Figure 112010054670377-pat00140

(식중, Ts는
Figure 112010054670377-pat00141
이고, Me는 메틸임)
를 더 포함하는 것을 특징으로 하는 syn-비닐클로로하이드린의 제조 방법.
The method of claim 29, wherein the step (a),
(a1) reacting a compound of Formula 2, butyllithium and a compound of Formula 4 to obtain a compound of Formula 6; And
(2)
Figure 112010054670377-pat00136

[Chemical Formula 4]
Figure 112010054670377-pat00137

Wherein Me is methyl
[Chemical Formula 6]
Figure 112010054670377-pat00138

(Ts is
Figure 112010054670377-pat00139
Me is methyl)
(a2) reacting the compound of Formula 6 with tetrahydrothiophene to provide a chlorine-containing sulfonium ion of Formula 9
[Chemical Formula 9]
Figure 112010054670377-pat00140

(Ts is
Figure 112010054670377-pat00141
Me is methyl)
Method of producing a syn-vinyl chlorohydrin further comprises.
KR1020100082150A 2010-02-26 2010-08-24 New chloride-containing allylating reagents and stereoselective ppeparation method of derivatives of vinyl chlorohydrins and vinyl oxiranes using the same KR101241744B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20100017773 2010-02-26
KR1020100017773 2010-02-26

Publications (2)

Publication Number Publication Date
KR20110098599A KR20110098599A (en) 2011-09-01
KR101241744B1 true KR101241744B1 (en) 2013-03-14

Family

ID=44952122

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100082150A KR101241744B1 (en) 2010-02-26 2010-08-24 New chloride-containing allylating reagents and stereoselective ppeparation method of derivatives of vinyl chlorohydrins and vinyl oxiranes using the same

Country Status (1)

Country Link
KR (1) KR101241744B1 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
오승주. 2009. 성균관대학교대학원 화학과 석사학위논문 *
오승주. 2009. 성균관대학교대학원 화학과 석사학위논문*

Also Published As

Publication number Publication date
KR20110098599A (en) 2011-09-01

Similar Documents

Publication Publication Date Title
Ramón et al. First enantioselective addition of diethylzinc and dimethylzinc to prostereogenic ketones catalysed by camphorsulfonamide-titanium alkoxide derivatives
Klunder et al. Asymmetric epoxidation of allyl alcohol: efficient routes to homochiral. beta.-adrenergic blocking agents
Kitanosono et al. Chiral-Sc catalyzed asymmetric Michael addition/protonation of thiols with enones in water
JP2017504562A (en) Furan-2,5-dimethanol and (tetrahydrofuran-2,5-diyl) dimethanol sulfonate and its derivatives
Marshall et al. Chirality transfer in the [2, 3] Wittig rearrangement
KR101241744B1 (en) New chloride-containing allylating reagents and stereoselective ppeparation method of derivatives of vinyl chlorohydrins and vinyl oxiranes using the same
Valverde et al. Preparation of (4 R, 5 S)-(5-methyl-2, 2-dimethyl-1, 3-dioxolane-4-ylmethyl)-phosphonium iodide. A synthetic approach to olguine: further model studies
Tiecco et al. Intramolecular addition of carbon radicals to aldehydes: synthesis of enantiopure tetrahydrofuran-3-ols
CN109970560B (en) Preparation method of tri-substituted 1, 3-diene compound
CN111646958B (en) Preparation method of carfilzomib
CN107513056A (en) A kind of synthetic method of the quinolines of the group containing tetrahydrofuran
Yadav et al. A Short Synthesis of (-)-Frontalin
CN101835745B (en) Process for production of disulfonic acid compound, asymmetric mannich catalyst, process for production of beta-aminocarbonyl derivative, and novel disulfonate salt
US4384127A (en) Process for synthesis of optically pure prostaglandin E2 and analogs thereof
KR102529680B1 (en) Method for synthesizing nebivolol and intermediate compounds thereof
Zhu et al. Template effect of Pd (II) in the synthesis of differently substituted enantiopure γ-butyrolactones and its synthetic applications
WO2003074534A9 (en) Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions
Concellon et al. Unusual Totally Selective Cyclodimerization of Epoxides: Synthesis of a Pair of Diastereoisomers of Enantiopure 2, 5‐Disubstituted‐1, 4‐Dioxanes with C2 Symmetry
Akiyama et al. Reactions of cyclic sulfur ylides with some carbonyl compounds
WO2016088138A1 (en) Diphenyloxiranes, process for preparation thereof, and its use in an enantioselective synthesis of (+)-sertraline
Harden et al. Lewis acid-catalysed rearragnement/reduction of 1-phenyloxiranemethanamines: synthesis of β-phenethylamines
FI92583B (en) Process for the preparation of optically active 3-thiolanyl sulfonate esters
JP7185624B2 (en) Method for producing optically active substance, optically active substance, method for producing chiral molecule, and chiral molecule
Guevel et al. An enzyme-based synthesis of (S)-(−)-3-methyl-2-[(phenylsiilfonyl)-methyl] butyl phenyl sulfide and the stereochemical course of its alkylation
Ishizaki et al. Synthesis of novel C2‐symmetrical chiral sulfides and their utility in asymmetric epoxidation of aldehydes

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160113

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20170102

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20181206

Year of fee payment: 6

R401 Registration of restoration
LAPS Lapse due to unpaid annual fee